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Abstract 
 
The Wnt pathway controls cell fate during embryonic development. It also persists as 
a key regulator of homeostasis in adult self-renewing tissues. In these tissues, mutational 
deregulation of the Wnt cascade is closely associated with malignant transformation. The 
intestinal epithelium represents the best-understood example for the closely linked roles of 
Wnt signaling in homeostatic self-renewal and malignant transformation. In this review, we 
outline current understanding of the physiological role of Wnt signaling in intestinal biology. 
From this perspective, we then describe how mutational subversion of the Wnt cascade leads 
to colorectal cancer (CRC). 
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Introduction 
 
Development and homeostasis in all multi-cellular organisms depend on a complex 
interplay between processes involved in cell proliferation, migration, differentiation, adhesion, 
and death. This diverse array of cellular responses is in large part coordinated by a relatively 
small number of intercellular signals, examples of which include the BMP, TGF, Notch, Hh, 
and Wnt pathways. One of the major developments in recent years has been the realization 
that the signaling pathways triggered by these factors are very often deregulated in 
pathological conditions (1-6).  This notion is particularly well illustrated by the role of the 
Wnt pathway in the intestinal epithelium. The relevance of Wnt signaling to intestinal biology 
was established, unknowingly at the time, over ten years ago when the tumor suppressor gene 
Adenomatous polyposis coli (APC) was found mutated in a large number of hereditary and 
sporadic cases of CRC (7-9). Subsequently, combined work from several laboratories led to 
the finding that inactivation of APC in CRC cells results in constitutively active Wnt 
signaling (10-12). Since these early findings a much richer picture has emerged. It is now 
recognized that Wnt signaling not only drives tumorigenesis but is also required at different 
stages of gut development, as well as during adult epithelial homeostasis. Our approach in 
this review will be to dissect the different functions attributed to Wnt signaling at these 
various time points.  First, we shall begin by introducing some of the components of the 
pathway most relevant to our discussion. 
  
A short summary of the Wnt pathway  
Wnts and their downstream effectors were originally discovered in Drosophila and 
subsequently shown to be conserved in all metazoans (13). Genetic and biochemical data 
taken from these models has, to date, identified over 50 proteins directly involved in 
transducing Wnt signals (see Wnt homepage at www.stanford.edu/~rnusse/ wntwindow.html).  
How these proteins interact with one another to stimulate various biological responses has 
been an area of intense investigation. 
 
Wnt genes, of which there are 19 in man and mice, encode for cysteine-rich 
glycoproteins. Production of biologically active Wnts depends on palmitoylation of a 
conserved cysteine residue (14). This process may be mediated by Porcupine/MOM1, 
however direct proof for this has not yet been provided (15-17). Once released into the 
extracellular milieu, Wnts interact with secreted proteins such as SFRPs and WIF (18). In 
general, these factors are thought to function as inhibitors by sequestering Wnts and 
preventing their interaction with membrane-bound receptors. Other interaction partners 
include membrane-anchored heparan sulfate proteoglycans (HSPGs). In Drosophila, the 
HSPG Dally acts as a positive regulator of Wnt activity, but its precise biochemical function 
is unknown (19).   
 
Wnts activate responding cells by interacting with the seven-span transmembrane 
protein Frizzled (Fz) and the single-span transmembrane protein LRP (20-23).  Two 
functional complexes involving these proteins have been described. Wnts may simultaneously  
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Figure 1. The Wnt 
Canonical Pathway.  
Left: in the absence of Wnt 
stimulation β-catenin levels 
are kept at a minimum 
through the destruction 
complex composed of APC, 
Axin, GSK3β, and CKI. In 
the nucleus Tcf factors 
associate with transcriptional 
repressors to block target 
gene activation. Right: in the 
presence of Wnt stimulation, 
the destruction complex is 
destabilized and β-catenin 
accumulates in the nucleus to 
activate transcription of Tcf 
target genes. 
 
 
 
bind to Fz and LRP. This represents the initial step in the so-called canonical pathway, which 
leads to the formation of nuclear Tcf/β-catenin complexes. Alternatively, when LRP is not 
expressed or downmodulated through secreted factors such as Dickkopfs (24), Wnts may 
nonetheless form a complex with Fz, triggering Tcf/β-catenin-independent cellular responses 
such as increased calcium flux, repression of Tcf-mediated transcription and cytoskeletal 
rearrangements.  Collectively, these responses are often referred to as non-canonical signaling 
(25). As of yet, this aspect of Wnt signaling has not been analyzed in the gut. For this reason, 
non-canonical Wnt signaling will not be covered in this review. 
 
The key component of the Wnt canonical cascade is the cytoplasmic protein β-catenin. 
In the absence of Wnts, the scaffolding proteins APC and Axin/Axin2 sequester β-catenin 
allowing casein kinase I (CKI) to phosphorylate the N-terminus of β-catenin at serine S45, a 
residue often mutated in cancers (26;27). Subsequently, glycogen synthase kinase 3 beta 
(GSK3β) is recruited to phosphorylate additional serine and threonine residues N-terminal to 
S45 (28). Phosphorylated β-catenin is then recognized by the F-box-containing protein β-
TrCP, which mediates ubiquitination and proteosomal degradation of β-catenin (29-31). 
Together, these proteins make up the so-called β-catenin destruction complex. As we shall see 
later, this complex plays a central role in the (de)regulation of intestinal homeostasis.  
 
Under physiological conditions, continued destruction of β-catenin is interrupted 
following Wnt binding to Fz/LRP. How the destruction complex senses Wnts at the cell 
surface is not fully understood. It has been assumed that the adapter protein Dsh through its 
association with Fz and the GSK3β-binding protein, Frat, may participate in this process (32-
34). Note however that recent genetic evidence excludes an essential requirement for Frat in 
Wnt signaling, since mice with deletions in all three Frat family members develop entirely 
13 
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normally (35). In parallel, Wnts induce phosphorylation of the cytoplasmic tail of LRP, which 
allows docking of Axin to LRP (36).  Recruitment of Axin to the membrane is thought to 
disrupt the destruction complex thereby releasing β-catenin. Lastly, it has been suggested that 
stabilization of β-catenin may be promoted by the protein phosphatase PP2A, which appears 
to dephosphorylate GSK3β substrates including β-catenin (37).  
Once released from the destruction complex, β-catenin translocates to the nucleus 
where it associates with the Tcf family of transcription factors (Tcf1, Lef, Tcf3 and Tcf4) 
(38).  Tcfs function by targeting β-catenin to specific DNA elements found in promoters and 
enhancers of target genes (39;40). In turn, β-catenin recruits a number of nuclear factors 
responsible for transactivating Tcf target genes. Two of these factors include the histone 
acetylase CBP/p300 and the SWI/SNF component BRG1 (41-43). Activation of target genes 
also depends on the nuclear proteins Legless and Pygopus (44-46). It has been proposed that 
Legless and Pygopus are involved in directly activating transcription, possibly by recruiting 
chromatin remodelling factors.  Legless and Pygopus may also function by transporting β-
catenin to the nucleus (47). Finally it is worth noting that in the absence of nuclear β-catenin 
or when nuclear β-catenin is sequestered by factors such as ICAT and Chibby (48;49), Tcfs 
associate with general transcriptional repressors like Groucho (50;51).  The latter silence 
target genes, in part, by recruiting histone deacetylases (HDACs), which render chromatin 
structure inaccessible to the basal transcriptional machinery. For an overview of the canonical 
Wnt pathway see Figure 1. 
 
Wnt signaling in and the origin of intestinal epithelial cells 
 
The intestinal epithelium originates from embryonic endoderm, which in turn stems 
from pluripotent epiblast cells at the onset of gastrulation (E6.0 in mice).  During this stage, 
epiblast cells committed to form definitive endoderm ingress through the primitive streak 
displacing visceral endoderm. The first endodermal cells to travel through the primitive streak 
populate the anterior end of the embryo, whereas endoderm leaving at later stages colonizes 
more posterior regions.  From E7.5-E9.5, the endodermal lining covering the mesoderm and 
ectoderm undergoes a series of invaginations initiated at the anterior and posterior ends of the 
embryo resulting in the formation of a proper gut tube (Figure 2). At this stage, the primitive 
gut is composed of a uniform layer of cuboidal endodermal cells surrounded by splanchnic 
mesoderm. The intestine along with the other organs derived from endoderm only become 
morphologically evident during a patterning phase (E9.5-14.5) in which the primordial gut is 
subdivided and reshaped along the anterior-posterior axis (Figure 2). For a thorough treatment 
of gut development see (52;53) . 
 
The earliest role attributed to Wnt signaling during gut development was initially 
uncovered in ascidian embryos, where β-catenin was found to be essential for endoderm 
formation (54). Through gene targeting experiments, Kemler and colleagues showed that this 
function of β-catenin is evolutionarily conserved in mice (55). Ablation of β-catenin 
specifically in the node, notochord and anterior primitive streak abrogated definitive 
endoderm formation.  Moreover, analysis of chimeric embryos showed that β-catenin-mutant 
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cells of the endodermal layer were unable to form endoderm but rather differentiated into 
precardiac mesoderm.  
 
How β-catenin promotes definitive endoderm formation is unclear. Recent data has 
suggested that in endodermal cells, β-catenin may not necessarily act through Tcf factors. 
Indeed, Sinner et al. have proposed that in frogs, β-catenin drives the expression of endoderm 
specific target genes by physically associating with Sox17, an HMG box transcription factor, 
related to Tcfs (56). Given that in zebrafish and mice Sox17 also plays a role in the formation 
of definitive endoderm (57;58), it will be interesting to test whether the Sox17/β-catenin 
complex may represent a generalized mechanism for promoting endoderm specification. 
Another unanswered question raised by these findings regards the identity of the Wnt(s) 
stimulating β-catenin in the endoderm. In mice, Wnt3 is a possible candidate, since in Wnt3-
mutant embryos, the epiblast remains undifferentiated while the primitive streak does not 
form. Moreover, the expression of both mesodermal and definitive endodermal markers is 
abolished (59).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Time-line of intestinal development in the mouse. 
Definitive endodermal cells are specified at E6.0 during gastrulation. The first panel from the left shows the 
bottom view of an E8.5 embryo, along with a schematic representation of the primitive gut. At E8.5 endodermal 
tube formation is initiated by folding (depicted by arrows) of the endodermal lining at the anterior and posterior 
ends creating anterior and caudal intestinal portals (AIP and CIP). The endodermal lining is stained with a probe 
recognizing Foxa1.  At later stages (E9.5-E14.5) the primitive gut tube is patterned along the anterior-posterior 
axis. The expression of specific intestinal markers first appears in the hindgut at E9.0 (168;169).The second 
panel from the left shows a whole mount preparation of the entire gastro-intestinal tract (E12.5) stained for the 
intestinal marker Villin. Villus formation and cytodifferentiation (formation of enterocytes, goblet cells, 
enteroendocrine cells and Paneth cells) is initiated at E14.5. In the third panel from the left, sections from the 
small intestine were stained for the proliferation marker Ki67. Mutations associated with the Wnt pathway affect 
gut development at various stages (see text).  Figure adapted from (53) 
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We have recently shown that Wnt signaling is required for gut tube formation (60). 
During this stage (E8.5), in situ hybridisation analysis revealed overlapping expression of 
Tcf4 and Tcf1in the hindgut. Simultaneous disruption of both genes led to severe defects in 
the formation of the hindgut and associated loss of expression of endodermal markers. This 
phenotype implies the existence of a Wnt source at the posterior end of the embryo, which 
would promote morphogenesis of the hindgut. A similar mechanism is utilized to drive 
posterior paraxial mesoderm and somite formation. In this case, Wnt3a expression in the 
presomitic mesoderm of the tailbud activates Lef and Tcf1 (61). Anterior tube formation may 
also depend on the activity of Wnt signaling components.  Analysis of APC hypomorphic 
mutant mice (APCneoR) has shown that expression of APC in the endoderm is required for the 
involuting movements, which generate the foregut pocket (see AIP in Figure 2) (62). The 
foregut defects in APC hypomorphs may result from the increased β-catenin/Tcf 
transcriptional activity in endodermal cells or may be ascribed to an alternative role for APC 
in cell migration.   
   
Our analysis of Tcf4/Tcf1 mutant embryos at later stages also revealed malformations 
of the gastrointestinal tract consistent with both factors playing a role in patterning the gut 
(60).  As could be expected from the early defects in hindgut formation, the intestine of Tcf4-/-
/Tcf1-/- embryos is severely truncated.  However, closer inspection uncovered anterior 
transformations at the stomach-duodenal junction. Expression analysis using specific markers 
of stomach and intestine revealed duplications of the stomach, suggesting that Tcf4 and Tcf1 
promote an “intestinal” fate within the primitive gut and in their absence more anterior 
regions of the gut are expanded. Evidence supporting this interpretation was recently provided 
by Hogan and co-workers (63) who showed that when a constitutively active form of β-
catenin is missexpressed in the lung endoderm, these cells turn on genes normally restricted to 
the intestine, implying once again that Wnt signals instruct endodermal cells to become 
intestine as opposed to other endodermal lineages. 
 
Wnt signaling and adult intestinal homeostasis  
 
Once the basic structure of the intestinal tract is laid out, differentiation along the 
radial axis may take place (see Figure 2 and 3).  During this process the epithelium of the 
small intestine is remodelled to form characteristic finger-like projections (villi) and deep 
invaginations termed crypts. Similar events take place in the colon, where crypts form but 
where a flat surface epithelium exists instead of villi.  These events coincide with the 
compartmentalization and cyto-differentiation of the epithelium.  The intervillus regions of 
the fetal intestine, which are replaced by crypts in the first weeks after birth, are lined with 
highly proliferative progenitor cells.  These transit-amplifying cells give rise to two 
differentiated cell lineages (ie. the absorbtive enterocytes and secretory cells). The secretory 
lineage can be further subdivided into mucus-secreting goblet cells, hormone-secreting 
enteroendocrine cells and bactericidal Paneth cells. Maturation of progenitor cells coincides 
with upward migration. Upon reaching the tips of the villi or the surface epithelium of the 
colon, the differentiated cells undergo apoptosis and are shed into the lumen. One exception 
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to this rule is the Paneth cell, which is generated from a progenitor migrating downwards 
toward the crypt base.  The self-renewing capacity of the intestine depends on the existence of 
stem cells (64). Classical labelling experiments have shown that in the small intestine stem 
cells reside just above the Paneth cell compartment, while in the colon they occupy the first 
cell position at the crypt bottom.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Adult intestinal homeostasis. 
Panel A and B. Schematic representation and section of the crypt-villus unit in the mature small intestine. 
Proliferative cells reside in the crypts, while differentiated cells occupy the villus. Crypt progenitors migrate up 
(red arrow) the crypt-villus axis before shedding into the lumen. The process of epithelial renewal takes 3-6 days 
and is ensured by a small number of asymmetrically dividing stem cells at the bottom of the crypts. Wnt 
signaling in the adult intestine promotes proliferation of progenitor or transit-amplifying (TA) cells, as well as, 
commitment towards secretory lineages Wnt signaling may also drive terminal differentiation of certain 
secretory lineages (see text).  Although it is commonly believed that Wnt signaling may promote proliferation 
and/or differentiation of intestinal stem cells, there is no evidence, which formally proves this (see arrows with 
question marks).  In panel A, black arrowheads indicate Ki67 positive transit-amplifying cells, while white 
arrowheads indicate the Paneth cell compartment. 
 
 There are now several lines of in vivo evidence, which show that normal proliferation 
of the transit-amplifying cells is entirely dependent on continual stimulation of the Wnt 
pathway. Firstly, removal of Tcf4, β-catenin or overexpression of the Wnt inhibitor Dkk-1 
results in a severe loss of proliferative epithelial cells in both the fetal and adult intestine (65-
68). Cell cycle arrest is also observed in CRC cell lines in which β-catenin/Tcf activity is 
blocked either through expression of dominant negative Tcf4 or knockdown of β-catenin 
(69;70). Consistent with these results, mutations in the negative regulator of Wnt signaling 
APC, or overexpression of oncogenic forms of β-catenin result in hyperproliferation of the 
epithelium (9;71-73). Lastly, progenitors located at the bottom of the crypts accumulate 
nuclear β-catenin implying that these cells respond to Wnt stimulation (69). Although these 
studies confirm the strong link between Wnt signalling and maintenance of transit-amplifying 
cells, it should be noted that virtually no evidence exists to draw a similar link between Wnt 
signals and stem cells (Figure 3). Part of the difficulty in tackling this issue is related to our 
lack of reliable markers of intestinal stem cells. Besides proliferation, we may also consider 
the accumulating evidence implying an additional function for Wnt signaling in driving the 
17 
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differentiation of secretory lineages. Indeed, blocking active Wnt signaling in vivo results in a 
reduction or absence of goblet, enteroendocrine and Paneth cells, while enterocytes appear 
spared (65;66;68). 
 
 Supported by these findings, a model can be proposed whereby transit-amplifying 
cells responding to a source of Wnts at the crypt bottom proliferate and concomitantly 
commit themselves to the secretory lineage. As these progenitors move up the crypt and 
further away from the Wnt source, Tcf/β-catenin activity is turned off, thus favouring cell-
cycle arrest and terminal differentiation. This simplistic view overlooks a number of issues. In 
our discussion, below we shall highlight four major questions: What is the genetic program 
regulated by Tcf/β-catenin in crypt progenitors? Where and what is the Wnt source? How 
does Wnt signaling regulate secretory cell lineage commitment? And finally, how is Wnt 
signaling turned off? 
 
Tcf/β-catenin target genes  
Most studies aimed at identifying Tcf/β-catenin target genes (for simplicity the term 
target gene here refers to either direct or indirect Wnt-responsive genes) in intestinal cells 
have made use of systems in which β-catenin is constitutively activated such as in CRC cell 
lines (see Table I for a selected list of Tcf target genes). Consequently as we shall see later, 
the majority of Tcf/β-catenin target genes have been associated with various processes 
important for tumorigenesis (ie cellular proliferation, survival and motility). Given that many 
of these genes are also expressed in normal crypt progenitor cells (69), efforts are now being 
undertaken, through classical loss or gain of function experiments in mice, to test their 
function during intestinal development and homeostasis. So far, however, only a limited 
number Tcf/β-catenin targets have been tested in vivo.  
 
The proliferative effects of Wnt signaling on crypt progenitors have, for some time 
now, been linked to cell cycle regulators such as c-Myc and cyclin D1 (74-76). Both factors 
are overexpressed in colorectal tumors and blocking expression of either gene inhibits 
proliferation in CRC cell lines (69;77;78) . However, cyclin D1 null mice do not appear to 
exhibit any abnormalities in the intestine, other than a modest reduction in the propensity to 
develop polyps when crossed with the APCmin mice (79). This observation suggests that other 
cyclin Ds may be more relevant downstream β-catenin/Tcf target genes. Along these lines, 
our own observations have shown that cyclin D2 is an early downstream Tcf4 target in the 
fetal gut (Gregorieff and Clevers, unpublished data). Moreover, microarray studies have 
shown that cyclin D1 levels do not appear to be affected when conditionally deleting APC 
(73). C-Myc has been confirmed as a Tcf/β-catenin target in vivo (68;80), although its precise 
function in normal epithelial cells remains to be clarified. In the bone marrow, recent 
evidence suggests that c-Myc promotes the release of hemopoietic stem cells from the stem 
cell niche by regulating the expression levels of adhesion molecules (81). In the skin, ectopic 
expression of c-Myc diverts epidermal stem cells to a sebaceous gland fate at the expense of 
hair follicles (82).  Whether c-Myc performs similar functions in the intestine will need to be 
examined by a conditional knock-out approach. 
 
18 
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Another Tcf/β-catenin target gene, which has been implicated in promoting 
proliferation is Id2 (69;83). The Id proteins represent a family of naturally occurring 
inhibitors of basic helix-loop-helix transcription (bHLH) factors, and function in many 
circumstances to prevent differentiation (84). In particular, Id2 is highly abundant in several 
cancer types and when forcibly expressed in colon cancer cell lines Id2 has been shown to 
increase anchorage-independent survival (83). Recent in vivo evidence, on the contrary, 
suggests that Id2 may have a completely different role in crypt progenitor cells (85).  In the 
Id2 knockout intestines, differentiation of endoderm is impaired during the late fetal stages 
(E18.5). Consequently the villi in several areas appear replaced by multilayered, 
undifferentiated endoderm. These areas of pseudostratified epithelium later develop into 
dysplastic and metaplastic tumours exhibiting high levels of nuclear β-catenin. Interestingly, 
these lesions also show a loss of Paneth cells and enteroendocrine cells and increased 
numbers of Goblet cells. 
  
Expression profiling has also identified genes implicated in many other processes 
besides the control of proliferation and/or differentiation. The tyrosine kinase receptors 
EphB2 and EphB3 and their ligand ephrin B1 illustrate this point (86). Consistent with their 
well-known roles in cell sorting in various tissues, these receptor/ligands pairs are expressed 
in an inverse gradient along the crypt-villus axis, with EphB2 and -B3 high in crypt cells and 
their ligand ephrin-B1 predominating in the villi. This expression pattern is tightly regulated 
both in vitro and in vivo by Tcf/β-catenin.   In vivo confirmation of the importance of these 
molecules came from the analysis of EphB2-/-B3-/- KO.  In these mice, proliferative and 
differentiated cell populations intermingle. Furthermore in EphB3-/- mice, Paneth cells no 
longer home to the crypt bottom, but rather scatter along crypts and villi. Thus, a Wnt 
signalling gradient controls cell positioning along the crypt-villus axis through regulation of 
EphB2 and EphB3 gene expression. 
 
The functional characterization of Tcf/β-catenin target genes will continue to be a 
major focus of interest for the coming years. We shall return to this issue in the context of 
colon carcinogenesis.  
 
The Wnt source 
The exact location or identity of the Wnts that drive proliferation is unclear. 
Nevertheless it is believed that mesenchymal cells or, more specifically, intestinal 
subepithelial myofibroblasts (ISEMFs), immediately adjacent to crypt epithelial cells, are a 
source of Wnts (87;88). This notion is based in part on classic co-culture experiments, which 
have shown that these cells are able to simulate proliferation of epithelial cells (89)   We 
recently tested this hypothesis by screening all 19 Wnts for expression in the adult intestine 
(Gregorieff and Clevers manuscript submitted). Through this approach we found several Wnts 
expressed in crypt epithelial cells, but so far none were detected in ISEMFs. Ablation of the 
Wnt genes associated with crypt epithelial cells will be required to test their function.  Until 
then, if we are to assume that these Wnts drive proliferation, then the next obvious question is 
what regulates Wnt expression in the epithelium.  Here once again we may have to turn to 
19 
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ISEMFs. These cells are known to produce paracrine growth factors (90), which conceivably 
could activate Wnt gene expression in the epithelium. This idea however remains speculative.  
 
On a related issue, genetic evidence in mice has identified two transcription factors, 
FoxL1 and Nkx2.3, involved in regulating growth signals emanating from the mesenchyme 
(91-93). Deletion of either gene in mesenchymal cells results in increased epithelial 
proliferation, suggesting that FoxL1 and Nkx2.3 normally play an inhibitory role. Kaestner 
and colleagues observed upregulation of the HSPGs, Syndecan1 and Perlecan, in FoxL1-/- 
mice (94). Although HSPGs have been implicated in stimulating Wnt signals (19;94), it 
remains to be tested whether these changes are a cause or an effect of the increased 
proliferation. 
 
Cell lineage commitment 
 The disproportionate reduction in goblet, enteroendocrine and Paneth cell numbers, 
resulting from the ablation of Wnt signals, suggests a definite role for Wnts in specifying 
secretory lineages.  Recently, some general rules for cell lineage commitment in the intestine 
have been uncovered. Precursors of all three secretory cell types express the bHLH factor, 
MATH1. Accordingly, MATH1 deficient mice lack goblet, enteroendocrine and Paneth cells 
but do produce enterocytes (95). The latter cells derive from progenitors expressing Hes1, 
based on the fact that Hes1-/- intestines display increased numbers of secretory cells at the 
expense of enterocytes (96). Interestingly, Hes1 transcription is activated by Notch signaling 
in other biological models (97), while Hes1 transcriptionally represses MATH1 expression 
(96;98). Together these findings suggest a model whereby commitment towards the 
enterocyte lineage would be favoured in cells with active Notch signaling, turning on Hes1 
transcription. Inversely, in the absence of Notch signaling, MATH1 would be upregulated 
skewing the cells towards secretory lineages (Figure 3B).  
 
 Further commitment towards specific cell types depends on yet other transcription 
factors. For example, the activation of NGN3, BETA2, Pax4 and Pax6 is associated with 
enteroendocrine (sub-)lineages (99), while differentiation of goblet cells is influenced by 
KLF4 (100). Moreover, in ELF3-/-  mice differentiation of absorptive and goblet cells is 
impaired (101).  
 
The connection between Wnt signaling and any of these factors remains an open 
question. One putative link was suggested by the observation, as we have mentioned earlier, 
that ablation of the Wnt target gene and bHLH antagonist Id2, results in impaired production 
of secretory lineages (85).  It is plausible that Id2 may mediate these effects by directly 
antagonizing the activity of certain bHLH trancription factors such as MATH1.  Alternatively, 
Wnt signals may directly activate the expression of genes involved in cell lineage 
commitment. Although no evidence for this exists so far, expression profiling of mouse 
models displaying impaired Wnt signaling suggests that the final stages of maturation of 
secretory lineages may depend on active Wnts signals. In particular, we and others find that 
20 
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the expression of Paneth cell markers, such as anti-microbial peptides (i.e. cryptdins and 
defensins), are directly stimulated by β-catenin/Tcf (102;103).  
 
-Counteracting Wnt signaling 
There are two non-mutually exclusive mechanisms, which could explain how the 
stimulatory effects of the Wnt cascade are turned off in the intestine.  In one scenario, 
activation of Wnt signals would gradually and passively dissipate as progenitors migrate up 
along the crypt-villi axis in sites where canonical Wnts are limiting. On the other hand, a 
more active mechanism may be utilized, involving “negative” cross-talk between the Wnt 
pathway and other signaling pathways. As we shall discuss below the TGFβ and BMP 
cascades are associated with growth inhibition in the gut, and thus may represent examples of 
Wnt-counteracting pathways. 
 
TGFβ signaling components are localized in differentiated epithelial cells, where they 
have well-documented growth suppressive effects (104). Furthermore, in both man and 
mouse, benign adenomas acquire invasive properties following the acquisition of inactivating 
mutations in the TGFβ-RII receptor or the intracellular signaling components Smad2 and 4 
(105-107). Mice with germline mutations in Smad3 and the latent TGFβ binding protein 4 
(LTBP-4) also develop colorectal cancer (108;109). Several groups have described 
mechanisms by which TGFβ signals could antagonize Wnt signaling in the intestine. One 
possible route may involve the alternative TGFβ effector and MAPKKK, TAKI. In 
Caenorhabditis elegans and mammalian cells activation of TAK1 stimulates the activity of 
the MAPK, NLK, which in turn, downregulates Tcf (110;111). Alternatively, Sasaki et al. 
have shown that TGFβ stimulation inhibits Tcf4/β-catenin transactivation of c-Myc via the 
ability of Smad3 to physically interact with β-catenin and thereby decouple Tcf4/β-catenin 
complexes (112).  
 
Similar inhibitory functions have been attributed to BMPs. BMP2 and BMP4 are 
expressed in mature epithelial cells and villus mesenchyme, respectively.  Moreover, both 
factors appear to activate their downstream signaling components SMAD1, 5 and 8 in the 
differentiated epithelium (113;114). Patients harbouring mutations in BMP signalling 
components suffer from juvenile polyposis syndrome (JPS), which is characterized by the 
formation of hamartomatous polyps throughout the gastrointestinal tract (115-117). Similar 
polyps are formed in the stomach and duodenum of Smad4 heterozygous mice. Insight into 
how these defects occur was recently provided by the generation of transgenic mice 
expressing the BMP inhibitor, Noggin, in the intestinal epithelium (113) and in mice in which 
the BMPR1A gene was conditionally deleted in the intestinal epithelium (118). In both cases, 
these mice develop lesions equivalent to those found in JPS. At the earliest stages in the 
development of these lesions, BMP inhibition results in de novo crypt formation combined 
with increased numbers of proliferative cells in normally differentiated compartments of the 
villi. Based on these observations, it appears that BMP signaling may restrict ectopic Wnt-
mediated proliferation in the differentiated epithelial cells and thereby confine crypt 
formation to regions immediately adjacent to the muscularis. How BMPs would antagonize 
21 
Introduction 
Wnt signaling in the intestine still remains to be clarified. However, a tentative model has 
been proposed by He et al. (118), in which BMP4 somehow promotes PTEN activation in 
intestinal stem cells, which in turn would repress β-catenin/Tcf activity through the PI3 
kinase-AKT pathway.  These results await further confirmation.  
 
Another class of signaling molecule, which may oppose the effects of Wnt signaling 
in the intestine are the Hedgehogs (Hh). The available evidence supporting such a role is 
somewhat conflicting. During chick and mouse, development Sonic hedgehog (Shh) and 
Indian hedgehog (Ihh) play multiple roles in patterning of the gastrointestinal tract (119-123). 
Both proteins have been implicated in the growth of upper-digestive tract tumours (124;125).  
Van den Brink et al. examined the role of Ihh signaling in the colonic epithelium (126). In the 
human colon, Ihh is uniquely expressed amongst non-proliferative cells of the surface 
epithelium. Accordingly, rats treated with cyclopamine, a small-molecule inhibitor of Hh 
signalling, displayed defects in enterocyte differentiation and an increase in the number of 
cycling cells per crypt.  These authors also showed that Ihh signaling in vitro interferes 
directly with β-catenin/Tcf transcriptional activity. More recently, ectopic epithelial 
proliferation was also reported in mice transgenically expressing the pan-Hh inhibitor HIP in 
the intestinal epithelium (88).  However, ablation of Hhs in mice by homologous 
recombination contradicts these results (122).  Ihh deficient mice display a loss of enteric 
neurons and as a result develop dilated colons reminiscent of Hirschprung's disease; while in 
the small intestine, the number of cycling epithelial cells is reduced.  Shh mutant mice show 
intestinal metaplasia in the stomach and duodenal stenosis. 
 
Wnt signaling and colorectal cancer 
 
In humans, sporadic and hereditary forms of colorectal cancer develop along a well-
defined sequence of histopathological changes (127).  The earliest lesions occurring in the 
colonic epithelium - aberrant crypt foci (ACF) - are characterized by dysplastic or 
hyperplastic crypts. Subsequent expansion of the ACF generates larger adenomas, which in 
turn may progress to carcinoma in situ and invasive adenocarcinomas. Because these lesions 
are easily identifiable, researchers have been able to characterize the genetic alterations 
associated with each stage (104;127)). The earliest mutations identified in the adenoma-to-
carcinoma sequence alter the function of components of the Wnt pathway. Mutations in APC 
are responsible for an inherited form of CRC, termed familial adenomatous polyposis (FAP) 
(7;8). Moreover, the overwhelming majority (80%) of early adenomas from sporadic cases of 
CRC bear truncating mutations in APC (9). Some of the remaining cases of CRC result from 
mutations in β-catenin, and Axin2 (128-130). Below we shall discuss how activating 
mutations in the Wnt cascade confer upon cells a selective growth advantage, which allows 
for the initial expansion of the precancerous lesion.  
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Table I. List of β-catenin/Tcf target genes tested functionally in vitro or in vivo.  
Gene Type LOF/GOF Ref. 
c-Myc -bHLH transcription 
factor  
-knock-down blocks 
proliferation  
(69;74) 
Cyclin D1 -cell cycle regulator -cyclinD1-/-/APCmin/+ show 
reduced polyp burden 
(75;76;79)  
Id2 -inhibitor of bHLH 
transcription factors 
-Id2-/- develop tumors  
and show impaired 
differentiation  
(83;85)  
ITF-2 - bHLH transcription 
factor 
-overexpression promotes 
neoplastic transformation 
(155)  
Tcf1 -Wnt signaling -Tcf1-/-/ APCmin/+ show 
increased polyp burden 
(145)  
PPARδ -ligand-activated 
transcription factors 
-PPARδ-/-/ APCmin/+ show 
increased polyp burden 
-treatment with PPARδ 
agonist, GW501516, 
increases number and size of 
polyps in APCmin/+ 
(142;156-158) 
COX-2 -prostaglandin pathway -COX-2-/-/ APC∆716/+ show 
reduced polyp burden 
(143;144;159) 
HDAC2 -histone deactylase -treatment with HDAC2 
inhibitor, valproic acid, 
reduces polyp number in 
APCmin/+  mice 
(160) 
FGF18 -growth factor -knock-down suppresses 
growth of CRC cells 
(140) 
FGF20 -growth factor -knock-down suppresses 
anchorage-independent 
growth 
(161) 
Endothelin -growth factor -rescues growth arrest and 
apoptosis resulting from 
blocking β-catenin  
(162) 
Gastrin -gastrointestinal growth 
factor and hormone 
-Gastrin-/-/ APCmin/+  show 
reduced polyp burden 
(139) 
BAMBI -BMP and activin 
membrane-bound 
inhibitor 
-overexpression blocks 
TGFβ-mediated growth 
inhibition 
(163) 
MMP7/ 
Matrilysin 
-ECM protease -MMP7-/-/ APCmin/+ show 
reduced polyp burden 
(81) 
Nr-CAM -adhesion -overexpression increases 
cellular motility 
(137) 
Mdr1 -ABC transporter  -Mdr-/-/ APCmin/+ show 
reduced polyp burden 
(164;165) 
ENC1 -BTB/Kelch protein 
family member 
-overexpression increases 
growth rate in CRC cells 
(166) 
APCDD1 -unknown -knockdown inhibits 
cell/tumor growth 
(167) 
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Consequences of hyper-active Wnt signaling  
  The immediate consequences of mutations in APC and β-catenin are well understood. 
β-catenin mutations disrupt the CK1/GSK3β phosphorylation sites at the N-terminus of the 
protein (128;131). Consequently, mutant β-catenin is no longer recognized by β-TrCP and 
becomes stabilized.  In turn, mutant β-catenin is free to enter the nucleus and constitutively 
activate transcription through Tcfs. Equivalent effects result from APC inactivation. 
Truncation of APC removes repetitive elements within the protein responsible for binding to 
β-catenin and Axin (132). As a result, GSK3β phosphorylation and subsequent degradation of 
β-catenin is severely impaired. Frameshift mutations in Axin2 eliminate its DIX domain 
required for homo-oligomerization. Although expression of mutant Axin2 in cells results in 
increased β-catenin accumulation, it is unkown how mutant Axin2 interferes with the 
destruction complex (129).   
 
Besides affecting the function of the destruction complex, mutations in APC have 
been proposed to disrupt its ability to regulate β-catenin function in the nucleus (132;133). 
For example, APC contains both nuclear export and import signals which allow it to act as a 
nuclear-cytoplasmic shuttle. Once in the nucleus APC promotes export of β-catenin and 
thereby deactivation of Tcf-mediated transcription, a property lost by mutation of APC 
(134;135). Alternatively, by associating with the transcriptional repressor CtBP, APC may 
also interfere with the formation of β-catenin/Tcf complexes (136). Whether these additional 
pathways regulating β-catenin activity play a significant role in neoplastic transformation 
remains to be determined. 
 
How does constitutive β-catenin/Tcf transcriptional activity promote adenoma 
formation?   As we first discussed in the context of homeostasis, the Wnt pathway normally 
promotes proliferation of progenitor cells. It is silenced when these cells exit the crypt 
compartment. In general terms, we may say that adenomas result from the unabated 
expansion of cells, which have adopted a crypt progenitor-phenotype. Consequently, the 
genes activated by aberrant β-catenin/Tcf activity in CRC cells simply reflect the normal 
genetic program of crypt progenitors (69).The identity and function of these target genes has 
been a hot topic in recent years. Today, the number of candidate β-catenin/Tcf effector genes 
has exploded and includes genes which may intervene in the cell cycle (c-myc, cyclinD1), 
tumor cell migration (eg. MMPs, Nr-CAM) (81;137) , survival (eg. Survivin) (138), growth 
(eg. FGF18, Gastrin) (139;140), as well as angiogenesis (VEGF) (141) and prostaglandin 
signaling (eg. COX-2, PPARδ) (142-144). A complete description of all putative Tcf target 
genes identified so far would be well beyond the scope of this review. Instead we refer the 
reader to Table I, which highlights target genes that have been tested functionally in CRC 
cells. 
 
Of particular relevance to this review is the observation that aberrant β-catenin/Tcf 
activity also leads to transcriptional upregulation of components of the Wnt signaling 
pathway proper. In colon cancer cells, both Tcf1 and Lef are strongly upregulated through 
direct activation by Tcf4. Genetic evidence in mice has shown that Tcf1 acts as tumor 
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suppressor (145). Tcf1 knockout mice display a predisposition towards developing 
spontaneous intestinal adenomas and polyp counts are greatly increased in APCmin/+ mice 
lacking Tcf1. One untested hypothesis put forward to explain these results is the suggestion 
that in colon cancer cells Tcf4 promotes expression of dominant-negative isoforms of Tcf1, 
lacking the β-catenin interaction domain. As such, activation of Tcf1 expression would 
constitute a negative feedback loop involved in inhibiting high levels of β-catenin/Tcf 
activity.  The effects of upregulating Lef in tumour cells have not been tested in vivo. 
However, Lef is likely to play a positive role in tumorigenesis based on the observation that 
Tcf4 specifically activates transcription of full-length Lef isoforms capable of interacting with 
β-catenin (146). In addition, Lef has been shown to harbour distinct biochemical properties 
when compared to Tcf4. For instance, Lef, contrary to Tcf4, appears to be refractory to the 
inhibitory effects of a TGFβ-Smad3 pathway (112).  
 
Another β-catenin/Tcf target gene and Wnt signaling component relevant to cancer is 
Axin2. In normal cells, as part of a negative feedback mechanism, Axin2 is upregulated 
following Wnt stimulation (147-149). As we have described earlier, this apparently attenuates 
excessive Wnt stimulation since inactivating mutations in Axin2 promote tumorigenesis. 
Upregulating Axin2 in adenomas may also serve to suppress the effects of aberrant β-catenin 
signaling. This idea is supported by the finding that overexpression of Axin in CRC cell lines 
bearing mutations in APC (but not β-catenin) downregulates β-catenin levels (150). The 
significance of these observations awaits further in vivo confirmation. 
 
New players in Wnt pathway-driven colorectal cancer? 
Given the predominant role of the Wnt pathway in CRC and many other types of 
cancer, several laboratories have shifted their attention on other Wnt signaling components 
besides the usual culprits such as APC and β-catenin. Recently, two groups have documented, 
in a high percentage of human colorectal adenomas and aberrant crypt foci, epigenetic 
silencing of the genes encoding for SFRPs (151;152). Suzuki et al. followed up on these 
initial observations by testing the impact of expressing SFRPs in CRC cell lines. Transfection 
of SFRP1, 2 and 5 in HCT116 and SW480 cells decreased β-catenin levels and transcriptional 
activity and resulted in growth inhibition and apoptosis. However, in similar experiments 
performed by Bafico et al., SFRP1 only had inhibitory effects on engineered HCT116 cells 
containing a single wild type β-catenin allele, whereas parental HCT116 cells with both wild 
type and mutant alleles or HCT116 cells containing only a mutant allele were insensitive to 
SFRP1 (153). Despite these discrepancies both groups show that HCT116 produce several 
Wnts and that treatment with SFRPs blocks autocrine Wnt-induced proliferation. Taking into 
account the results from Bafico et al., it is more likely that silencing of SFRPs would only 
provide a growth advantage before mutations in APC and β-catenin have occurred. At later 
stages of tumorigenesis when cancer cells constitutively express high levels of β-catenin, 
disrupting Wnt function would most likely be inconsequential.   
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Concluding remarks 
 As we have highlighted in this article, the intestinal epithelium provides an attractive 
system to study how Wnt signaling regulates cellular growth and differentiation. Current 
evidence validates the Wnt cascade -in particular the β-catenin/Tcf4 complex- as a target for 
therapeutic strategies in the treatment of CRC. Breaching the interaction between β-catenin 
and Tcf in cancers using small organic molecules will be a hard nut to crack. Yet, some 
promising results have recently been reported by Shivdasani and colleagues (154). The 
challenge in the long term will be to translate our increasing knowledge of the biochemical 
and functional features of the Wnt pathway into effective therapeutic strategies to combat 
cancer. 
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Outline of the thesis 
 
 
 As was discussed in the introduction, the intestine has served as a useful model system 
to investigate the biological role of the Wnt pathway. Over the years, a great deal of attention 
has been directed towards unraveling the link between mutations in Wnt signaling 
components and initiation of colon carcinogenesis. The first major breakthrough came with 
the discovery that APC and β-catenin mutations result in increased Tcf-driven transcriptional 
activation. Through the identification of Tcf-mediated target genes it later became clear that 
the Wnt pathway controls a genetic program involved in maintaining intestinal epithelial cells 
in a highly proliferative state. These observations provided a basic understanding of how 
activation of the Wnt pathway confers upon colon cancer cells a growth advantage, as well as 
revealed the importance of Wnt signaling during gut homeostasis. However having said this, 
numerous questions regarding Wnt signaling and its role in the intestine have largely been left 
unexplored. This thesis attempts to address some of these issues.  
 
 One of the objectives was to investigate how Wnt signaling affects early development 
of the gut. In Chapter 2, we present evidence which shows how in gastrulating embryos, Tcf4 
and Tcf1 act redundantly to promote expansion of the primitive hindgut. We also show that at 
later stages loss of both Tcf4 and Tcf1 results in patterning defects of the gastro-intestinal 
tract. The goal of Chapter 3 was to determine the identity and localization of the Wnt 
signaling components expressed in the fetal and adult intestine. To tackle this issue we 
performed an extensive in situ hybridization screen of all known Wnt ligands, receptors, 
antagonists, as well as Tcf factors. This analysis allowed us to uncover factors putatively 
involved in regulating both canonical and non-canonical Wnt signals. In Chapters 4 and 5, 
with the prior knowledge that Tcf4 is required to maintain proliferation of intestinal epithelial 
cells, we sought-out to uncover genes regulated by Tcf4 during late fetal development. 
Paradoxically, this approach revealed that Wnt signaling regulates genes normally expressed 
in secretory lineages (ie. goblet cells, Paneth cells and enteroendocrine cells).  These 
observations indicate that Wnt signaling promotes proliferation of progenitor cells and 
concomitantly favors their differentiation.  
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Abstract 
 
Wnt signalling plays a critical role in both initiating and patterning of the anterior-posterior 
(A-P) axis during development. Wnts exert their biological effects, in part, by activating 
specific target genes through members of the TCF/LEF family of transcription factors. To 
gain new insight into the role of T-cell factors (or Tcf’s) during development we analysed 
Tcf4 and Tcf1 compound null embryos. These mutants showed severe caudal truncations, as 
well as duplications of the neural tube. Unlike other mutations affecting Wnt signalling, 
paraxial mesoderm formation was not impaired and early caudal markers, such as T, were 
unaffected. Analysis of endodermal markers uncovered early and specific defects in hindgut 
expansion and later an anterior transformation of the gastro-intestinal tract. Our results reveal 
a novel role for Wnt signalling in early gut morphogenesis and suggest that specific Wnt-
driven patterning events are determined by the unique tissue distribution of Tcf/Lef family 
members.  
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Introduction 
 
During mouse development, the anterior-posterior (A-P) axis becomes 
morphologically evident at the onset of gastrulation. At this point, the epiblast cell layer at the 
posterior end of the embryo forms a structure known as the primitive streak.  Cells at the 
streak delaminate and migrate forward and laterally to form both mesodermal and endodermal 
layers. As gastrulation proceeds at the posterior end, body structures such as head, trunk, 
limbs and tail are specified along the A-P axis. This process of patterning and later 
organogenesis depends on a complex network of instructive signals, ultimately determining 
whether cells within the developing embryo proliferate, differentiate, or die. 
 
Amongst the most important regulators of cell fate decisions during both formation 
and patterning of the A-P axis are members of the Wnt/Wg family of secreted factors. Wnts 
make up a large family of cystein-rich glycoproteins that activate signalling cascades that 
induce cytoplasmic responses and/or transcription of target genes [for reviews see (13;170-
172). The latter depends on cytoplasmic accumulation of β-catenin and its translocation to the 
nucleus where it associates with the TCF/LEF family members (comprised of TCF1, LEF, 
TCF3, TCF4). Formation of this bipartite complex provides a template for the recruitment of 
additional transcriptional activators that finally turns on expression of specific target genes. 
Importantly, in the absence of Wnts, TCF/LEF proteins can actively block transcription by 
recruiting general repressors like Groucho and CtBP (173;174). In this way TCF/LEF proteins 
act as molecular switches that control cell fate decisions. 
 
Perhaps the first indication that the Wnt/β-catenin/TCF pathway was required for 
determining the A-P axis came from microinjection experiments conducted in Xenopus 
embryos. Ectopic expression of Wnts, for example, induces axis duplications and can rescue 
UV irradiated embryos (175;176). In addition, gene-targeting experiments in mice have 
provided a wealth of information confirming an essential role for Wnt signalling in axis 
formation.  Mutations disrupting Wnt signalling, such as Wnt3 and β-catenin knock-outs, 
completely impair formation of the primitive streak and resulting embryos remain as egg 
cylinders lacking posterior specification (59;177).  On the other hand, mutations in Axin and 
APC which lead to increased β-catenin/TCF-mediated transcription, cause axis duplications 
similar to those observed in Xenopus (178).  Similarly, ablation of Tcf3 results in duplications 
of the node and notochord, as well as upregulation of axial markers, such as Foxa2, implying 
that Tcf3 acts primarily as a transcriptional repressor involved in  restricting AP axis 
induction (179). 
 
Deletion of other components of the Wnt cascade has shown that Wnt signals are also 
required for patterning and/or expansion of the mouse embryonic axis once it has formed. 
Mutations in Wnt1 lead to deletion of the midbrain and cerebellar component of the hindbrain 
(180). Dkk-/- embryos display a disruption of forebrain and cephalic neural crest-derived 
tissues as well as limb morphogenesis defects (181). Wnt3a-/- and Lef -/-/Tcf1-/- embryos show 
severe caudal truncations of the embryonic axis, resulting from an early loss of mesodermal 
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structures (ie. somites) (61;182;183). The absence of Wnt5a results in a general shortening of 
the embryonic axis, including limbs (184). Finally, loss of LRP6, an essential Wnt-coreceptor, 
recapitulates many of the phenotypes described above, with disrupted patterning in the brain, 
limbs, neural tube and tail (21).  
 
Besides the phenotype of Lef -/-/Tcf1-/- and Tcf3-/- embryos described above, limited 
information is available about the function of other Tcf/Lef genes during early mouse 
development. Lef -/- mice die perinatally lacking teeth, hair follicles and mammary glands 
(185). Further analysis has also demonstrated impaired hippocampus development and 
generation of dentate gyrus granule cells in Lef deficient mice (186). Tcf1 homozygous null 
mice are viable but demonstrate an early blockage in thymocyte differentiation, as well as 
increased susceptibility to form mammary gland and intestinal neoplasms (145;187). Tcf4-/- 
mice die at birth due to a loss of epithelial stem cells in the small intestine (66). In order to 
gain further insight into the function of Tcf/Lef genes during morphogenesis, we generated 
compound Tcf4-/-/Tcf1-/- mice. These mutants display profound caudal truncations similar to 
Wnt3a-/- and Lef -/-/Tcf1-/- embryos, although unlike the latter, Tcf4-/-/Tcf1-/- embryos retain 
paraxial mesoderm. Rather, the primary patterning defect appears to result from aberrant 
hindgut expansion, ultimately leading to homeotic shifts of the fetal gastro-intestinal tract.    
 
Results 
 
Tcf4-/-/Tcf1-/- mutants show posterior truncations. 
To study the consequences of inactivating both Tcf1 and Tcf4 during embryonic 
development we crossed Tcf4+/- and Tcf1-/- mice. Although smaller than wild-type 
counterparts, Tcf4+/-/Tcf1-/- mice appeared normal. Compound homozygous null embryos, 
however, did not survive past gestation. Viable double mutants were obtained at the expected 
frequency until E14.5. Examination of Tcf4-/-/Tcf1-/- embryos at this stage showed major 
abnormalities in the development of caudal structures while anterior structures were spared. 
As shown in Figure 1, Tcf4-/-/Tcf1-/- mutants lacked hindlimbs, posterior body and tail. 
Although formation of hindlimbs was affected, forelimbs were normal suggesting that the loss 
of hindlimbs reflect a general patterning defect, rather than a specific problem in limb 
development. In more severely truncated embryos internal organs were exposed indicating a 
failure of the abdominal wall to properly develop (Figure 1C and D). Hematoxylin/eosin 
stainings of sections of the specimen depicted in Figure 1B revealed that most internal 
structures, including lungs, heart, pancreas, and liver were clearly distinguished and 
histologically appeared normal (Figure 1F and data not shown). Even more caudal structures 
such as kidneys and mesonephric ducts had formed and differentiated. This may imply that 
Tcf4 and Tcf1 are not required for early morphogenesis of these organs. Closer examination of 
Tcf4-/-/Tcf1-/- mutants, however, showed a complete absence of the genital tubercle, hindgut 
and only a remnant of the urogenital sinus, as well as signs of aberrant branching of neural 
tube (Figure 1D, F and below). 
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Figure 1. Tcf4-/-/Tcf1-/- embryos show severe 
caudal truncations. 
Lateral views of E14.5 embryos.  (A) Tcf4+/-/Tcf1-
/- and (B-D) Tcf4-/-/Tcf1-/- littermates.  Panel B 
shows vestigial hindlimbs and the absence of a 
tail in mutant embryos. In more severe cases as 
depicted in panels C and D internal organs such 
as the gut and liver are exposed. In several 
instances the neural tube branched out in mutant 
embryos as shown in D and F (see arrow). Panels 
E and F represent hematoxylin and eosin 
stainings of sections of embryos depicted in A 
and B respectively. Various structures are 
identified as follows: (H) heart, (Lu) lungs, (L) 
liver, (K) kidneys, (U) urogenital sinus, (MD) 
mesonephric duct, (GT) genital tubercle, (SI) 
small intestine, (HG) hindgut, and (N) neural 
tube.    
 
 
 
Duplications of the neural tube in Tcf4-/-/Tcf1-/- embryos. 
The posterior truncations observed in Tcf4-/-/Tcf1-/- embryos were reminiscent of 
Wnt3a-/- mutants. Analysis of these mice, as well as Lef -/-/Tcf1-/- embryos, revealed an early 
loss of paraxial mesoderm and concomitant formation of ectopic neural tubes (61;188). To 
characterize the fate of paraxial mesoderm vs. neural tissue in Tcf4-/-/Tcf1-/- embryos, we 
began our analysis by examining the expression of the neural tube marker Wnt-1 in E10.5 
embryos. As shown by whole-mount in situ hybridization, Wnt-1 expression along the 
anterior portion of Tcf4-/-/Tcf1-/- embryos was comparable to that of normal littermates (Figure 
2). Towards the posterior end, ectopic Wnt-1 expression was detected, reflecting bifurcations 
or splitting of the neural tube (Figure 2D, see arrow). Sectioning through the mutant embryos 
confirmed the occurrence of duplications of the neural tube (Figure 2E).  
 
Paraxial mesoderm formation is unaffected in Tcf4-/-/Tcf1-/- embryos. 
To follow the fate of paraxial mesoderm we employed three somitic markers, Paraxis, 
Pax1 and Myf5. Detection of Paraxis transcripts, normally present in sclerotome and 
dermamyotome compartments, clearly distinguished the presence of somitic tissue along the 
entire A-P axis of Tcf4-/-/Tcf1-/- embryos (Figure 3B). Note however that the somites at the 
caudal end did appear disorganized. Even in a specimen displaying a more severe truncation, 
the sclerotome marker, Pax1, revealed that despite being smaller and less well defined, 
somites were present (Figure 3D).  Finally, we tested the myogenic marker, Myf5, and found 
once again that caudal somites had formed (Figure 3F). The maintenance of somitic markers 
was in stark contrast to the previously described Lef -/-/Tcf1-/- phenotype, in which case Pax1 
expression was completely absent below the forelimbs (61). To confirm the differences 
between the two crosses we generated Lef -/-/Tcf1-/- embryos and verified the expression of 
Paraxis in these mutants (data not shown). As expected, Paraxis staining was abolished in the 
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caudal portion of these mutants, providing additional proof that contrary to Tcf4-/-/Tcf1-/- 
embryos, Lef  -/-/Tcf1-/- mutants lack somitic tissue. These results suggest that despite forming 
ectopic neural tissue, paraxial mesoderm fate is unaffected in Tcf4-/-/Tcf1-/- embryos. 
 
 
Figure 2. Duplications of the neural tube in Tcf4-/-/Tcf1-/- embryos. 
Whole-mount in situ hybridizations of E10.5 littermates using a Wnt1 probe as a marker for neural tube. (A) 
Tcf4+/-/Tcf1-/- embryo; (B) right side, (C) left side and (D) close-up views of a representative Tcf4-/-/Tcf1-/- 
embryo. Lateral and close-up views reveal that the neural tube appears to split at the caudal end of mutant 
embryos. In some regions (see arrow in D and the corresponding section in E) complete duplications of the 
neural tube are observed. Note that Wnt1 expression appears normal in the anterior half of Tcf4-/-/Tcf1-/- embryos.   
 
Next, we assessed whether expression of early caudal markers was impaired. Several 
genes expressed in the primitive streak and presomitic mesoderm have been reported to play 
an essential role during patterning of the caudal end of the mouse embryo. For example, 
mutations in T (Brachyury) cause a kinked tail phenotype and maintenance of T expression 
was shown to depend on intact TCF/LEF binding sites in its promoter (189;190).  However, 
in situ hybridization on both E8.5 and E9.5 embryos demonstrates that T expression is 
unaltered in Tcf4-/-/Tcf1-/- embryos (Figure 4A-D). These results contrast analysis of Lef -/-
/Tcf1-/- embryos where maintenance of T expression was abolished in the tail bud of E9.5 
embryos. We also tested Tbx6, another T box-containing family member implicated in 
posterior patterning (191). As shown in Figure 4E and F, Tbx6 transcripts were still detected, 
although the levels and range of expression was reduced compared to normal littermates. 
Cdx1 expression was shown to be down-regulated as early as E8.5 in Wnt3a deficient 
embryos, and in the fetal gut of Tcf4-/- mice (192;193). In spite of these observations, Figure 
4G, and H show that Cdx1 is not dependant on Tcf1/Tcf4, at least during gastrulation. Finally, 
we tested Wnt5a because of its essential role in expansion of the tailbud, but as with other 
markers tested (including Cdx2, Lef, Evx1 and Wnt3a, data not shown) no changes in 
expression were observed. Altogether these results provide further evidence that the 
patterning defects in Tcf4-/-/Tcf1-/- embryos cannot be directly attributed to loss of mesodermal 
precursors. 
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Figure 3. Paraxial mesoderm is intact in Tcf4-/-
/Tcf1-/- embryos. 
Whole-mount in situ hybridizations of E10.5 
littermates using markers for paraxial mesoderm.  
(A, C and E) Tcf4+/-/Tcf1-/- embryos and (B, D and 
F) Tcf4-/-/Tcf1-/- embryos.  Panels A and B show 
stainings for Paraxis, Panels C and D show Pax1 
stainings. Panels E and F show expression of Myf5. 
All three somitic markers confirm the presence of 
paraxial mesoderm throughout the axis of Tcf4-/-
/Tcf1-/- mutants. 
 
 
 
 
 
 
 
 
 
Figure 4. Expression of early posterior markers is 
unaffected in Tcf4-/-/Tcf1-/- embryos. 
Whole-mount in situ hybridizations of E8.5-9.5 
littermates using various posterior markers (see 
above). (A, C, E, G, I) Tcf4+/-/Tcf1-/- embryos and 
(B, D, F, H, J) Tcf4-/-/Tcf1-/- embryos.  Panels (A,B) 
and (C,D) represent E8.5 and E9.5 embryos 
respectively and show that initiation and 
maintenance of T expression is unchanged in Tcf4-/-
/Tcf1-/- embryos.   
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Expression of Tcf4, Tcf1 and Lef in the primitive gut. 
To gain further insight into the underlying causes of the Tcf4-/-/Tcf1-/- phenotype we 
reexamined the expression of Tcf/Lef family members. Previous analysis has shown 
overlapping expression of Tcf1 and Lef in the forelimbs and primitive streak region of 
gastrulating embryos (61;194). Somewhat surprisingly, in light of the caudal truncations 
observed in Tcf4-/-/Tcf1-/- embryos, Tcf4 transcripts were mainly detected in rostral structures, 
such as di- and mesencephalon and pharyngeal arches (61;195). To address this discrepancy 
we performed in situ hybridization on sections of E8.5 and E10.5 wild-type embryos focusing 
our attention on posterior structures. Sections through the primitive streak showed that the 
overall expression pattern of Tcf/Lef genes was only partially overlapping. At E8.5 Tcf4 was 
specifically detected in the hindgut. Tcf1 was expressed in the primitive ectoderm, presomitic 
mesoderm and hindgut. Lef was restricted to the presomitic mesoderm (Figure 5A-C). At later 
stages, we could distinguish Tcf4 expression in the neural tube and hindgut. Comparable 
sections showed that Tcf1 expression was maintained in all three germ layers, including the 
neural tube, presomitic mesoderm and hindgut. Importantly, Lef was excluded from the 
primitive gut and was expressed in mesodermal structures (Figure 5D-F). The tissue 
specificities of Tcf/Lef genes provided a rationale to explain the disparities between the 
phenotypes of the compound null mutants. The overlapping expression of Tcf1 and Lef in the 
presomitic mesoderm, coupled with the exclusion of Tcf4 in this compartment, may explain 
why Lef -/-/Tcf1-/- embryos, but not Tcf4-/-/Tcf1-/- embryos, lose caudal somites. By analogy, 
we reasoned that the primary anomaly in Tcf4-/-/Tcf1-/- embryos may be impaired hindgut 
development. Based on these observations we decided to analyze endodermal fate in Tcf4-/-
/Tcf1-/- embryos. 
 
 
Figure 5. Comparison of 
Tcf4, Tcf1 and Lef 
expression.  
In situ hybridization on 
sections of E8.5 and E10.5 
wild-type embryos were 
performed using specific 
probes recognizing Tcf4 (A, 
D), Tcf1 (B, E) and Lef (C, 
F).  Top panels (A-C) depict 
sections through the 
primitive streak region of 
E8.5 embryos, while bottom 
panels (D-E) show sections 
through the tail bud of 
E10.5 embryos. Various 
structures are identified as 
follows: (PE) primitive 
ectoderm, (NT) neural tube, 
(PSM) presomitic 
mesoderm and (HG) 
eural tube and hindgut. Tcf1 hindgut. Tcf4 was specifically expressed in the hindgut at E8.5 and at E10.5 in the n
was found in all three germ layers at both E8.5 and E10.5. Lef was detected in the presomitic mesoderm in both 
stages examined and was absent from the primitive gut. 
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Caudal endoderm is impaired in Tcf4-/-/Tcf1-/- but not Lef -/-/Tcf1-/- embryos.  
To follow gut development we analysed the expression of three endodermal markers 
-/- -/- -/- dermal tube 
formati
 
of caudal endoderm in Tcf4-/-
/Tcf1-/-embryos. 
 endodermal 
istol
r 
u
o
Sox17, Foxa1 and Shh in Tcf4 /Tcf1  and Lef -/-/Tcf1  embryos. At E8.5 endo
on is initiated by folding of the endodermal lining at the anterior and posterior ends 
creating anterior and caudal intestinal portals (AIP and CIP) [for reviews see (52;53)]. At this 
stage, Sox17 and Foxa1 are normally expressed along the entire endodermal lining in wild-
type embryos (Figure 6A and D). In Tcf4-/-/Tcf1-/- embryos, however, the caudal endoderm 
showed an absence of both Sox17 and Foxa1 staining (Figure 6B and E, see arrows). 
Conversely, in Lef -/-/Tcf1-/- embryos expression of both markers is uninterrupted (Figure 6C 
and F). At E9.5, the AIP and CIP join to close the endodermal tube resulting in formation of a 
proper foregut, midgut and hindgut. During this stage Shh expression is detected throughout 
the newly formed endodermal tube and clearly distinguishes the hindgut from the notochord 
at the posterior end (Figure 6G-I). In Tcf4-/-/Tcf1-/- embryos, only notochord staining is 
observed, indicating a  
 
Figure 6. Impaired expansion 
embryos maintain somites but the primitive gut tube has not closed. Simila
show a properly formed gut tube and the absence of somites (panel L). The ca
presence of ectopic neural tissue in both Tcf4-/-/Tcf1-/- and Lef  -/-/Tcf1-/- embry
Whole-mount in situ 
hybridizations of E8.5-9.5 
littermates using
markers and h ogy of E9.5 
normal and mutant embryos. 
(A,D,G, J, M) wild-type embryos 
and (B,E,H, K, N) Tcf4-/-/Tcf1-/-
embryos and (C,F,I, L, O) Lef  -/-
/Tcf1-/- embryos.  The arrows in 
B and E point to the loss of 
Sox17 and Foxa1 staining in the 
caudal endoderm of Tcf4-/-/Tcf1-/-, 
while staining is normal in Lef -/-
/Tcf1-/- embryos.  Arrows in G 
and I point to Shh expression in 
the hindgut of wild-type and Lef -
/-/Tcf1-/- embryos. The notochord 
in Tcf4-/-/Tcf1-/-embryos appears 
exposed due the absence of an 
underlying gut tube (arrowhead 
in H). Panels J-L and M-O 
represent hematoxylin and eosin 
stainings of sections through the 
midgut region and hindgut 
respectively. Various structures 
are identified as follows: (S) 
somites, (NT) neural tube), (MG) 
midgut and (HG) hindgut. Note 
in panel K that Tcf4-/-/Tcf1-/- 
sections in Lef  -/-/Tcf1-/- embryos 
dal sections (M-O) also reveal the 
s. 
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complete lack of the hindgut. As a result of the loss of underlying gut, the notochord appears 
exposed at the tail end of these embryos (Figure 6H, see arrowhead). Shh expression in Lef -/-
-/-/Tcf1  embryos was maintained in the hindgut (Figure 6I, see arrow), implying once again 
that the observed effects in Tcf4-/-/Tcf1-/- are specific. To confirm these data we prepared 
hematoxylin/eosin sections of wild-type, Tcf4-/-/Tcf1-/-, as well as Lef -/-/Tcf1-/- embryos. 
Sections through the midgut region (just posterior to the stomach) of Tcf4-/-/Tcf1-/- embryos 
revealed that the endodermal tube had not closed (Figure 6K). More caudal sections showed 
ectopic neural tissue and the absence of any hindgut (Figure 6N).  Equivalent regions in Lef -/-
/Tcf1-/- embryos demonstrated that the gut tube had formed despite the loss of somites and 
formation of multiple neural tubes (Figure 6L and O). Altogether these results implied that 
specification and expansion of the hindgut is aberrant in Tcf4-/-/Tcf1-/- embryos. 
 
Figure 7. Anteriorization of the gastro-intestinal tract in Tcf4-/-/Tcf1-/- embryos. 
(A) Whole-mount in situ hybridizations of dissected anterior gastro-intestinal tracts of E14.5 Tcf4+/-/Tcf1-/- (left) 
nd Tcf4-/-/Tcf1-/- (right) embryos using a stomach marker, Sox2.  The gastro-intestinal tract of the normal 
ct of Tcf4-/-/Tcf1-/- embryos 
a
embryo was severed to remove the intestinal tube. The truncated gastro-intestinal tra
is shown in its entirety. As shown by arrowheads, Sox2 expression is confined to the stomach in normal 
littermates, while ectopic expression in the duodenum is apparent in mutants. (B) In situ hybridizations on 
consecutive sections (i-iv) of a single E13.5 Tcf4+/-/Tcf1-/- gastro-duodenal preparation. Top and bottom rows of 
panels were stained for Sox2 (stomach) and Cdx2 (intestine) respectively. Top and bottom sections i-iv represent 
equivalent regions and should be compared with each other. Arrowheads indicate regions of positive staining for 
both probes (C) In situ hybridizations on consecutive sections (i-vi) of a single E13.5 Tcf4-/-/Tcf1-/- gastro-
duodenal preparation. Top and bottom sets of panels were stained for Sox2 and Cdx2 respectively. Sections i-vi 
represent equivalent regions and should be compared with each other. Various structures are identified as 
follows (S) stomach, (D) duodenum. Arrowheads in panels stained for Cdx2 represent regions of the duodenum 
which are devoid of Cdx2 expression but show high expression of Sox2. Note how the duodenum in mutants 
appears dilated compared to normal littermates (B).  In addition, Cdx2 transcripts are confined to a small portion 
of the duodenum, the remaining tissue expresses Sox2. Altogether these data provide evidence for the occurrence 
of an anterior transformation in the gastro-intestinal tract of Tcf4-/-/Tcf1-/- embryos. 
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Anterior transformation in the gastro-intestinal tract of Tcf4-/-/Tcf1-/- embryos.  
Given the specific defects in the formation of caudal endoderm in Tcf4-/-/Tcf1-/- 
embryos we also were interested in examining later patterning events of the gastro-intestinal 
tract.  As expected serial transverse sections of E14.5 embryos showed that the intestine of 
Tcf4-/-/Tcf1-/- mutants was severely truncated and ended blindly {Supplementary Figure 1 (see 
http://www.nature.com/ emboj/journal/v23/ n8/extref/7600191s1.pdf, bottom panels m-o}. 
Closer inspection of mutant embryos revealed profound patterning defects in the 
stomach/duodenum region. Normally, the stomach is restricted by the oesophageal junction at 
the proximal end and by the duodenal junction at the distal end {Supplementary Figure 1 (see 
http://www.nature.com/ emboj/journal/v23/n8/extref/7600191s1.pdf) top panels a-e}. While 
the boundary between the oesophagus and stomach was normal in Tcf4-/-/Tcf1-/- embryos, the 
duodenal opening was not clearly defined. In fact, serial sections suggested that the 
duodenum was dilated, giving the impression that the stomach had duplicated at the distal end 
{Supplementary Figure 1 http://www.nature.com/ emboj/journal/v23/n8/extref/ 
7600191s1.pdf, bottom panels}. To better visualize this we dissected out the stomach and 
intestine from E14.5 embryos in order to verify the expression of the epithelial stomach 
marker Sox2 (196). In Tcf4+/-/Tcf1-/- littermates Sox2 expression was restricted to the stomach 
with no transcripts detected beyond the duodenal boundary.  In Tcf4-/-/Tcf1-/- embryos, Sox2 
expression was present throughout the stomach and truncated intestinal tract. These results 
implied that the Tcf4-/-/Tcf1-/- gastro-intestinal tract was indeed anteriorized. To confirm this 
we performed in situ hybridisations on consecutive sections of normal and mutant 
stomach/duodenum preparations in order to verify the expression of the intestinal marker, 
Cdx2, alongside Sox2. As depicted in Figure 7, Sox2 and Cdx2 are confined to the stomach 
and duodenum respectively in normal littermates (see Figure Legends for details).  In mutant 
embryos, comparable sections showed that the duodenum only partially expressed Cdx2.  
Moreover, regions of the duodenum devoid of Cdx2 (see black arrowheads, comparing top 
and bottom sets of panels i-vi) abundantly expressed Sox2. Thus, the duodenum was 
apparently transformed into stomach, effectively leaving Tcf4-/-/Tcf1-/- embryos with little or 
no intestine.  
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Discussion 
 
In this report we show that deletion of Tcf1 and Tcf4 leads to an absence of caudal 
structures in the mouse embryo. These embryos displayed duplications of the neural tube and 
unlike other null mutants affecting Wnt signalling, Tcf4-/-/Tcf1-/- embryos retain paraxial 
mesoderm. By examining the expression of endodermal markers we found an early defect in 
the development of the hindgut and later patterning anomalies consistent with homeotic 
transformations of the gastro-intestinal tract. The specific defects in caudal endoderm and 
later axial truncations are reminiscent of recent experiments with chick embryo explants, 
where surgical removal of caudal endoderm leads to blunted tail development (197). 
Likewise, the impaired gut development in Sox17-/- embryos is accompanied by disorganized 
posterior trunk development which can partially be rescued in chimeras (58;198). Together 
these findings suggest that posterior endoderm may produce signals required for proper 
development not only of the hindgut but also adjacent structures.  Therefore in Tcf4-/-/Tcf1-/- 
embryos, the basis for the severe posterior truncations may be the result of arrested gut 
development. In light of this, the disorganized aspect of the paraxial mesoderm in some 
embryos may be attributed to the hindgut defects.  Further analysis will be required to test this 
hypothesis. 
 
Tcf/Lef genes regulate distinct patterning events 
The comparison between Tcf4-/-/Tcf1-/- and Lef -/-/Tcf1-/- embryos has allowed us to 
uncover distinct roles for Tcf/Lef family members during A-P patterning. Previous work and 
our own analysis indicate that Lef and Tcf1 are necessary for early specification of paraxial 
mesodermal. Lef -/-/Tcf1-/- embryos phenocopy null mutations in Wnt3a and also the putative 
target gene Tbx6 (191). The primary defect in these mutants appears to result from the 
formation of ectopic neural tissue at the expense of paraxial mesoderm. One model that has 
emerged to explain this phenomenon suggests that Wnt signals (namely Wnt3a–LEF/TCF1) 
instruct epiblast cells to adopt a mesodermal fate. When this signal is disrupted, involuting 
cells from the primitive streak fail to differentiate into mesoderm, and possibly by default, 
adopt a neuronal differentiation program, ultimately contributing to the formation of ectopic 
neural tissue where normally somites are formed.   
 
In Tcf4-/-/Tcf1-/- embryos, expression of posterior paraxial mesoderm markers is 
maintained, suggesting that Tcf4 is not required for specifying this tissue type.  Rather Tcf4 in 
concert with Tcf1 are necessary for the development of caudal endoderm. By analogy to the 
above model our results could also imply that during germ layer formation, Tcf4 and Tcf1 
regulate the formation and/or expansion of caudal endoderm at the expense of neural tissue. 
Thus the neural tube duplications in these embryos may result from unspecified epiblast cells 
forming ectopic neural tubes as described in Wnt3a-/- and Lef  -/-/Tcf1-/- mutants. Alternatively, 
the duplications in Tcf4-/-/Tcf1-/- embryos may reflect later intrinsic patterning defects caused 
by loss of Tcf4 and Tcf1 expression in the neural tube.  
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Wnt signals, therefore, pattern specific caudal structures through the differential usage 
or tissue distribution of Tcf4, Tcf1 and Lef. The absence of any defect in either paraxial 
mesoderm or caudal endoderm development in the single knockouts, however, argues that 
TCF/LEF factors are functionally redundant at the biochemical level. In other words, 
LEF/TCF1 in the paraxial mesoderm and TCF4/TCF1 in the caudal endoderm most likely 
regulate overlapping sets of target genes. However, these results do not exclude the possibility 
that within other cell types, co-expressed TCF/LEF factors control unique genetic programs. 
In favour of this notion, promoter studies have demonstrated that unique domains present 
within individual TCF/LEF proteins allow for the regulation of specific target genes 
(199;200). Moreover, forced expression of mutant version of Tcf3 and Lef in different model 
systems, such as Xenopus embryos and skin stem cells, results in distinct developmental 
outcomes (201;202). Thus, it appears that the exact contribution of individual TCF/LEF 
factors in response to Wnt signals depends on the cellular and developmental context.  
 
Both early and late stages of gastro-intestinal development are controlled by Wnt 
signalling   
The specific defects in the fetal gut development of Tcf4-/-/Tcf1-/- embryos are 
consistent with our previously described single Tcf4 knockout (66). The phenotype of these 
mice first becomes evident during villus formation in the small intestine at around E16.5 At 
this time point, proliferating epithelial cells normally detected in the inter-villus regions are 
lost and as a result Tcf4-/- mice die perinatally.  Given the importance of Tcf4 in maintaining 
epithelial stem cells in the small intestine, it is intriguing to speculate that Tcf4 may play an 
equivalent role in the primitive gut. A recent study in the chick provides additional evidence 
that Tcf/Lef factors are essential for gut development (203).  However, in this model 
expression profile analysis and loss of function studies predict a restricted role for Tcf4 and 
Lef in the development of the gizzard, the duodenum and ceca. 
 
The transformations of the gastro-intestinal tract highlight an unexpected role for Tcf4 
and Tcf1 in later patterning of the gut tube.  From E9.5-E14.5, once the endodermal tube has 
formed, specialized structures such as lungs, stomach, small intestine, colon etc. develop 
along the A-P axis.  During this patterning phase, both Tcf4 and Tcf1 are expressed in foregut 
derivatives such as the stomach (data not shown). Tcf4 is strongly expressed in the stomach 
epithelium.  Tcf1 expression appears much less abundant and transiently, with early 
expression in the stomach mesenchyme and later in the epithelium.  Because removal of Tcf4 
and Tcf1 leads to ectopic stomach tissue, this may reflect a role for both factors in restricting 
growth of the stomach while at the same time promoting growth of more caudal endodermal 
structures (ie. the midgut and hindgut). 
 
Besides regulating the expansion and patterning of the gastro-intestinal tract, a number 
of other functional studies implicate canonical Wnt signalling in other aspects of gut 
development. For example, the initial formation of definitive endoderm is severely impaired 
in conditional β-catenin mutant embryos; and as a result these embryos develop ectopic 
cardiac tissue (55). As a self-renewing tissue, the adult intestine also requires active Wnt 
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signalling to maintain proliferation of epithelial progenitors.  This was confirmed recently by 
two independent studies which showed that forced expression of the Wnt antagonist, Dkk1, 
blocks proliferation in the intestinal mucosa (67;68). On the other hand, several lines of 
evidence have shown that over-stimulation of the Wnt pathway, through activating mutations 
in components such as β-catenin and APC, promotes tumorigenesis (4;87). Altogether 
therefore these data imply that Wnt signalling is absolutely required for the formation, 
growth, patterning and homeostasis of the gut endoderm.  
 
In conclusion, the results presented here establish a novel role for Wnt signalling in 
early gut morphogenesis and underscore the importance of the Tcf/Lef genes in driving early 
patterning events during mouse development. Given the abundance of Wnts (19 described 
genes) and the probability that many have overlapping functions, future analysis of various 
compound Tcf/Lef null mutants should provide valuable models to dissect the role of 
canonical Wnt signalling in many other developmental processes. 
 
 
Experimental Procedures  
 
Mice 
Tcf4, Tcf1 and Lef  deficient mice were described elsewhere (66;185;187). Genotyping of all 
embryos was performed by PCR of genomic DNA isolated from extraembryonic tissue.  
Detailed protocols (including primer sequences) for genotyping will be provided upon 
request.  
 
Histology and in situ hybridization 
Embryos were dissected in PBS, fixed overnight in 4% paraformaldehyde and kept for long 
term storage in 100% methanol. For whole-mount in situ hybridization, embryos were 
rehydrated, digested in proteinase K, post-fixed, and hybridized overnight at 70°C with 
various probes in 5X SSC (pH 4.5), 50% Formamide, 2% Blocking Powder (Roche), 5mM 
EDTA, 50µg/ml yeast tRNA, 0.1% Tween 20, 0.5%CHAPS and 50µg/ml Heparin. Embryos 
were washed as follows: 2X SSC for 4X 10minutes at 70°C, 2X SSC/0.1% CHAPS for 2X 30 
minutes at 70°C, 100µg/ml RNAse A/2X SSC/0.1% CHAPS for 30 minutes at 37°C, and 
100mM maleic acid/150mM NaCl for 2X 30 minutes at 70°C. Embryos were washed in 
TBST, blocked for 2 hours in TBST containing 0.5% Blocking Powder and 1% sheep serum. 
Next embryos were incubated in blocking solution overnight at 4°C with preabsorbed alkaline 
phosphatase-conjugated anti-digoxigenin (1/2000 dilution) (Roche). Embryos were washed 
several times in TBST and color reaction was performed with BM Purple AP substrate 
(Roche). For Wnt1 stainings embryos were dehydrated, embedded in paraffin, sectioned and 
counterstained with 1.0% Neutral Red. For in situ hybridization on sections embryos were 
embedded in paraffin, sectioned at 10µM and processed for hybridization as above with the 
following modifications. Both CHAPS and Tween 20 were omitted from the hybridization 
buffer and post hybridization washes were performed as follows: 2X SSC for 5 minutes, 2X 
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SSC/50% Formamide for 3X 30 minutes at 65°C. Sections for histology studies were stained 
with hematoxylin and eosin.   
 
Probes 
The following probes were used for in situ hybridization studies: Pax1 (IMAGE clone 
#1327502), T (204), Wnt5a (205), Cdx1 (206), Lef (194), Foxa1 (207), Sox17 (58), Sox2 
(IMAGE clone # 5707193) Tcf1 (IMAGE clone #4016305) Tcf4 (IMAGE clone #4952976) 
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Abstract 
 
 Background & Aims: In the intestine the canonical Wnt signaling cascade plays a 
crucial role in driving proliferation of epithelial cells. Furthermore, aberrant activation of Wnt 
signaling is strongly associated with the development of colorectal cancer. Despite this 
evidence, little is known about the precise identity and localization of Wnts and their 
downstream effectors in the adult intestine. To address this issue we examined the expression 
pattern of all Wnts, Fzs, LRPs, Wnt antagonists and TCFs in the murine small intestine, colon 
and adenomas. Methods: Embryonic, postnatal and adult intestinal samples were subjected to 
in situ hybridisation using specific RNA probes for the various genes tested. Results: Our 
analysis revealed high expression of several signaling components (including Wnt-3, Wnt-6, 
Wnt-9b, Fz-4, Fz-6, Fz-7, LRP-5 and sFRP-5) in crypt epithelial cells.  We also detected Wnt-
2b, Wnt-4, Wnt-5a, Wnt-5b, Fz-4 and Fz-6 in differentiated epithelial and/or mesenchymal 
cells of the small intestine and colon. Finally, several factors (Fz-4, TCF-1, LEF, Dkk-2, Dkk-
3 and WIF) displayed differential expression in normal versus neoplastic tissue. Conclusion: 
Our study predicts a much broader role for Wnt signaling in gut development and 
homeostasis than was previously anticipated from available genetic studies and identifies 
novel factors likely involved in promoting canonical, as well as non-canonical Wnt signals in 
the intestine.   
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Introduction 
 
 The intestine harbors a variety of cell types, organized into highly regular structures, 
known as villi and crypts of Lieberkühn. The absorptive and protective functions of the gut 
are ensured by enterocytes, goblet cells, Paneth cells and enteroendocrine cells. These 
differentiated epithelial cells arise from transit amplifying progenitors and ultimately stem 
cells, both of which reside in the crypts. The intestine also consists of a layer of loose 
connective tissue or mesenchyme, which is thought to provide structural support and growth 
signals to the overlying epithelium. Finally, embedded within the various layers of the 
intestine, one additionally finds blood vessels, smooth muscle and neuronal cells, as well as 
lymphocytes. 
  
 Cellular proliferation and differentiation in the intestine depends on a large array of 
signaling molecules (104;208).  One such example includes the Wnt family of secreted 
growth factors (13;209;210).  Wnts are evolutionarily conserved, cysteine-rich glycoproteins, 
capable of signaling in both paracrine and autocrine fashion.  Wnts induce a wide range of 
biological effects by binding to the seven-span transmembrane protein, Frizzled (Fz) (20) and 
the single-span LDL receptor-related protein, LRP (21-23).  In a complex with Fz/LRP, Wnts 
trigger the release of β-catenin from a so-called destruction complex, which in the absence of 
Wnts, promotes ubiquitin-mediated degradation of β-catenin (209). Subsequently, free β-
catenin shuttles to the nucleus where it associates with DNA binding factors of the TCF (T-
cell factor) family in order to activate transcription of target genes (39;40). More recent 
evidence has shown that Wnts may also stimulate cellular responses, independently of β-
catenin and TCF (25;211).  Examples of these so-called non-canonical pathways involve 
either the intracellular release of calcium ions and activation of Ca++ dependent kinases or 
morphogenic changes dependent on RhoA and Jun kinase stimulation, also termed the planar 
cell polarity pathway. 
 
 Genetic studies have demonstrated an essential role for canonical Wnt signaling in 
regulating intestinal epithelial cell proliferation. One of the earliest indications of this came 
from the analysis of mutations in core Wnt signaling components such as APC and β-catenin 
(212-214). These genetic alterations lead to the formation of intestinal adenomas, as a result 
of deregulated nuclear accumulation of β-catenin and constitutive activation of target genes 
associated with proliferation of epithelial cells (73;215-217). Conversely, blockage of 
canonical Wnt signals in the intestine, either through deletion of TCF-4 or overexpression of 
the Wnt antagonist, Dkk-1, results in arrested epithelial cell proliferation (66-68).  Another 
function ascribed to Wnt signaling in epithelial cells was recently uncovered through DNA 
micro-array analysis.  EphB2 and B3 are TCF-4-responsive genes, which regulate upward 
movement of epithelial cells and the positioning of Paneth cells within the crypt-villus axis 
(86). Together these data provide clear evidence that proliferation, as well as sorting of crypt 
epithelial cells depends on the correct dosage of canonical Wnt signals.   
48 
 Chapter 3  
 
  Despite the functional evidence described above, relatively little is known about the 
localization of Wnt signaling components within the intestine. Expression studies in mice and 
chicks have shown that during embryonic development Wnt gene products are broadly 
expressed throughout the intestinal tract (203;218;219).  In the adult intestine Wnt expression 
is maintained (220)  but their precise localization remains unclear.  To address this issue in 
detail, we screened the expression patterns of all known Wnts, Fz/LRP and Wnt antagonists, 
as well as TCF family members in the adult intestine by in situ hybridization (ISH).   
 
 
Results 
 
Expression of Wnt genes in the adult intestine.  
 In order to provide a comprehensive expression profile of Wnt signaling components in 
the intestinal mucosa, we first collected and generated RNA probes for all murine Wnts (19 
nes), sFRPs (5 genes), Dkks (4 genes), WIF 
and Cerberus (see Materials and Methods).  
By ISH on sections, we initially examined 
the expression of Wnt genes in both 
embryonic and adult stages.  Of the 19 Wnt 
probes tested, 7  
 
genes), Fzs (10 genes), LRPs (2 genes), TCFs (4 ge
 
igure 1. ISH analysis of Wnts expressed in 
pressed in Paneth cells 
F
intestinal epithelial cells. 
Panels (a) shows Wnt-3 ex
(arrowheads). Panel (b and c) show Wnt-9b 
strongly and predominately expressed in Paneth 
cells in the distal portion of the intestine (ileum). 
Panel (d) represents a consecutive 4µm section of 
the same intestinal crypt as shown in panel (c) and 
was immunostained with an antibody recognizing 
the Paneth cell marker, lysozyme.  Panel (e) 
represents a section of the duodenum and shows 
Wnt-9b expression in Paneth cells and crypt 
progenitor cells. Panel (f) shows Wnt-9b expressed 
throughout the colonic epithelium.  Panels (g-i) 
show Wnt-6 in crypt epithelial cells of the small 
intestine and colon, as well as in adenomas 
respectively.  
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Wnts were readily detected in the intestine {results are recapitulated in Figure 6 and 
igure 2. ISH analysis of Wnts expressed in 
ows at E18.5 Wnt-5a 
Supplementary Table I (http://www.niob.knaw.nl/ researchpages/clevers/files)}.  As shown in 
Figures 1 and 2, Wnt ligands are expressed in both the epithelial and mesenchymal layers of the 
intestine.  In the epithelium, Wnt-3 was associated with the very bottom of the crypts of 
Lieberkühn, at the sites where Paneth cells are located (Figure 1a). Similarly, in the distal portion  
of the small intestine, Wnt-9b (also termed Wnt-14b) was found predominately at the bottom of 
the crypts (Figure 1b). To confirm the identity of these cells, we performed immunostainings on 
consecutive 4µm sections for the classical Paneth cell marker, lysozyme.  As shown on 
corresponding sections (Figure 1c and d) of the same intestinal crypt, Wnt-9b-expressing cells 
also produced lysozyme and thus represent Paneth cells. Interestingly, in more proximal areas of 
the small intestine Wnt-9b was also detected in epithelial progenitor cells above the Paneth cell 
compartment (Figure 1e). Contrary to the small intestine, in the colon Wnt-9b was localized 
throughout the colonic epithelium (Figure 1f). Moreover both Wnt-3 and 9b displayed weak 
expression in adenomas of APCmin mice (data not shown). Note that a recent report has 
additionally observed Wnt-9b expression in the fetal gut (221).  Finally, we found Wnt-6 
expressed throughout the crypts of the small intestine and colon (Figure 1g and h).  Similarly, 
Wnt-6 was strongly expressed in adenomas (Figure 1i). 
 
 
F
the mesenchyme of the small intestine and 
large intestine. 
Panel (a) sh
accumulation in the mesenchyme of the villi 
tips (red arrowheads), in mesenchymal cells 
adjacent to proliferative epithelial cells (black 
arrowheads), and in the smooth muscle layer 
(green arrowhead). The border between the 
epithelium and the mesenchyme is indicated 
with dashed lines.   In the mature intestine 
(panel b), Wnt-5a is strongly expressed in 
mesenchymal cells at the tips of villi (red 
arrowheads and inset), while levels are 
reduced along the villi towards the crypt-
villus border (black arrowheads). Panel (d) 
and a higher magnification in panel e show 
Wnt-5a upregulation in stromal cells of 
intestinal polyps (black arrowheads). Panels 
(c), (f) and (h) show Wnt-5a, Wnt-5b and Wnt-
4, respectively just beneath the surface 
epithelium of the colon. Note that Wnt-5a is 
also detected lower in the crypts (red 
arrowheads). Inset in panel (f) shows cross-
section of colonic crypts with Wnt-5b staining 
in surrounding mesenchyme. Panel (g) shows 
uniform Wnt-4 expression throughout the villi. 
Panels (i) and (j) show Wnt-2b in 
mesenchymal cells of the small intestine and 
endothelial or smooth muscle cells of the 
colon, respectively. 
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 Several Wnts were also found in specific compartments of the mesenchyme. In the fetal 
gut, Wnt-5a showed high expression at the tips of growing villi and in few discrete cells beneath 
the proliferative epithelium (Figure 2a).  In the adult small intestine, Wnt-5a was similarly 
abundant in the villus tips, although weaker expression was also observed throughout the villi, as 
well as at the crypt-villus junction (Figure 2b).  In the colon, Wnt-5a and the closely related Wnt-
5b were restricted to the mesenchyme beneath the surface epithelium (Figure 2c and f). Lastly, 
Wnt-5a, and to a lesser extent Wnt-5b, were both upregulated in stromal cells of APCmin polyps 
(Figure 2d, 2e and data not shown). Unlike Wnt-5a, Wnt-4 was uniformly expressed along the 
villus mesenchyme and absent from adenomas (Figure 2g and data not shown).  However, in the 
colon Wnt-4 expression closely resembled Wnt-5a and 5b stainings (Figure 2h). Finally, Wnt-2b 
was strongly expressed in the mesenchymal layer of the villi and more weakly in the crypts of 
the small intestine (Figure 2i). In the colon, Wnt-2b transcripts were less abundant and appeared 
to be markers of endothelial or smooth muscle cells (Figure 2j). 
 
 
Figure 3. ISH analysis of Wnt receptors in 
the intestine and colon. 
Panel (a) shows Fz-5 in the epithelium of the 
crypts and crypt-villus border. Panel (b) and (c) 
show Fz-7 in the lower portions of adult 
intestinal and colonic crypts, respectively. 
Panel (d) shows Fz-4 in differentiated epithelial 
cells of the villi. Note that expression of Fz-4 is 
strongest in the lower half of the villi. Panel (e) 
shows Fz-4 upregulated in intestinal polyps. 
Panel (f) and (g) show Fz-6 throughout the 
epithelium in both small and large intestine, 
respectively. Panel (h) shows LRP-5 restricted 
to proliferative epithelial cells. 
 
 
 
 
 
 
 
 
 
 
 
 
Expression of Wnt receptors in the adult intestine 
cells, we next examined the expression of  In order to identify putative Wnt-responsive 
Frizzled related receptors 1-10.  As indicated in Supplementary Table I (see 
http://www.niob.knaw.nl/researchpages/clevers/files) and Figure 3, several Fz genes were 
located in both the fetal and adult intestine. As shown in Figure 3a and in van Es et al. (57), Fz-5 
was detected in epithelial cells of the intervillus pockets of fetal guts and in the crypts of adult 
intestines.  In addition, Fz-7 and Fz-4 were dynamically expressed during intestinal 
development.  Fz-7 was strongly expressed in the smooth muscle layer and in inter-villus 
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epithelial cells of neonates (P1) (data not shown); although at later stages, Fz-7 was confined to 
the epithelium of the crypt bottom (Figure 3b and c). Fz-4 transcripts were also widely 
distributed in neonatal guts (Supplementary Table I), while expression in adults was 
comparatively weaker and restricted to differentiated epithelial cells of the villi (Figure 3d).  One 
notable exception to this was the high levels of Fz-4 in adenomas, as shown in Figure 3e. 
Finally, Fz-6 was uniformly expressed throughout the epithelium of the small and large intestine 
(Figures 3f and g).  We also tested the expression of LRP co-receptors, LRP-5 and 6, given their 
absolute requirement in driving canonical Wnt signals. As expected we found both LRP-5 and 6 
expressed in proliferative epithelial cells of the crypts (Figure 3h and data not shown). 
 
Figure 4. ISH analysis of secreted Wnt 
el (b) show 
     
e a family of secreted factors 
termed sFRPs (18;222).  Both Fzs and sFRPs share an equivalent Wnt-interacting, cysteine-rich 
antagonists in the small intestine. 
Panel (a) and the close-up in pan
sFRP-1 in mesenchymal cells surrounding the 
crypts.  Additional “spotty” staining is also 
detected in the smooth muscle layer (green 
arrowhead), while expression in the villi is 
reduced (red arrowhead). Panel (c) shows sFRP-
5 expression in all proliferative epithelial cells of 
the fetal (E16.5) intestine. Panel (d) shows 
sFRP-5 staining of single crypt epithelial cells in 
the adult small intestine. Insets show close-ups 
of two typical examples of sFRP-5 expression in 
single cells (black arrowheads), just above the 
Paneth cells (red arrowheads). Panel (e) shows 
sFRP-5 expression limited to the base of two 
consecutive colonic crypts. Panel (f) and (g) 
show WIF and Dkk-2 respectively, expressed 
only in intestinal polyps of APCmin mice (black 
arrowheads), while normal epithelium is devoid 
of any expression.  Panel (h) shows Dkk-3 
expressed in mesenchymal cells of the villi 
(black arrowhead) and plexi of the enteric 
nervous system (red arrowhead). Panel (i) shows 
Dkk-3 strongly up-regulated in APCmin polyps.     
 
  
 
 
 
 
 
 
 
 
 
Expression of secreted Wnt antagonists in the adult intestine 
 The functional counterparts of the Fz receptors includ
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do , which allows sFRPs to compete with Fzs and thereby antagonize Wnt signaling.  Of the 
five sFRP probes tested here, we only detected expression of sFRP-1 and 5.  In the small 
intestine and colon, mesenchymal cells immediately adjacent to the crypts, as well as cells within 
the submucosa expressed abundant levels of sFRP-1 (Figure 4a, b and data not shown). sFRP-5 
was strongly expressed in epithelial progenitor cells at E16.5 (Figure 4c).  However, in the 
mature intestine not all proliferative cells expressed sFRP-5.  Indeed, sFRP-5 transcripts were 
detected in single cells in positions within the intestinal and colonic crypts reminiscent of stem 
cells (Figure 4d and e) (64;223;224). In some instances we also found weaker sFRP-5 expression 
throughout the crypt bottom of the small intestine (data not shown). To further define the 
localization of sFRP-5-expressing cells within the crypts, double stainings were performed for 
both sFRP-5 and Lysozyme {Supplementary Figure 2c 
(http://www.niob.knaw.nl/researchpages/clevers/files)}. This approach showed that cells 
expre sFRP-5 were located immediately above the Paneth cell compartment. We were also 
interested in comparing the expression of  sFRP-5 with that of the proposed intestinal stem cell 
marker Musashi-1 (225-227). To test this we examined both sFRP-5 and Musashi-1 expression 
by in situ hybridization on consecutive sections.  As shown in Supplementary Figure 2a and b, 
we found that sFRP-5 displayed a more localized expression pattern than Musashi-1. Indeed, we 
observed the latter was expressed throughout the epithelial progenitor cell compartment.  Lastly, 
it is worth noting that sFRP-1 and sFRP-5 were not detected in intestinal polyps (data not 
shown). 
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Figure 5. ISH analysis of TCFs in the small and 
rge intestine. 
ughout the epithelium of the small 
la
Panel (a) and the higher magnification in panel (b) 
show TCF-4 thro
intestine (black arrowheads). TCF-4 also accumulates 
in the submucosal and myenteric ganglia of the 
enteric nervous system (red arrowheads).  Panel (c) 
shows high expression of TCF-4 in the upper half or 
non-cycling areas of the colonic crypts (black 
arrowheads), while expression is reduced in the lower 
half or proliferating cells (red arrowheads). Panel (d) 
shows a similar expression gradient with TCF-4 
antibodies. Panel e shows TCF-1 in epithelial cells of 
the crypt bottom (red arrowheads), in gut-associated 
lymphoid tissue (GALT) (green arrowhead) and 
putative infiltrating intestinal lymphocytes (black 
arrowheads). Panel (f) shows high expression of 
TCF-1 in Peyer’s patches. Panel (g) shows 
upregulation of TCF-1 in adenomas (red arrowheads) 
when compared to normal crypt epithelium (black 
arrowheads). Panel (h) shows ectopic expression of 
LEF in intestinal polyps (red arrowheads), whereas 
normal epithelium is devoid of LEF (black 
arrowheads). Panel (i) and inset show unique TCF-3 
expression in epithelial cells of colonic crypts.       
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Like sFRPs, other secreted factors can inhibit Wnt action by binding directly to Wnts as in the 
xpression of TCF family members in the intestine 
 of TCFs in gut development and cancer 
Another TCF family member previously implicated in regulating epithelial proliferation 
case of WIF and Cerberus (18;222) or by binding to LRP co-receptors, as with the Dkk class 
(24).  In Figure 4f we found WIF uniquely expressed in adenomas, confirming a recent report 
(228). Similarly, a Dkk-2 probe specifically stained adenomas (Figure 4g), whereas Dkk-3 was 
weakly expressed in the villus mesenchyme, myenteric plexi, and upregulated in adenomas 
(Figure 4h and i).  Dkk-1, Dkk-4 and Cerberus were undetected in the intestinal tract (data not 
shown). 
 
E
 Numerous studies have examined the function
(38). As shown in Figure 5a and b, a TCF-4 probe revealed staining along the entire crypt-villus 
axis, as well as in the enteric nervous system. TCF-4 expression was also maintained in 
adenomas (data not shown).  In the colon, TCF-4 transcripts were most abundant in 
differentiated cells of the surface epithelium, whereas expression diminished in the lower half of 
the crypts.  Because a role for TCF-4 in non-proliferative cells was not anticipated based on the 
available genetic data (66), we wished to confirm the ISH results with TCF-4 antibody stainings. 
When comparing equivalent regions within the colon (see panels 5c and d), we once again found 
TCF-4 expressed predominately in non-cycling cells away from the crypt bottom. 
 
 
is TCF-1. Indeed, APCmin mice crossed into a TCF-1 null background display increased numbers 
of intestinal polyps, implying that TCF-1 acts downstream of TCF-4/β-catenin and may play a 
role in cancerogenesis (145). In agreement with this, we found TCF-1 expression strongly up-
regulated in adenomas when compared to normal proliferative crypt cells (Figure 5g). However, 
we also observed TCF-1 transcripts in infiltrating gut lymphocytes, gut-associated lymphoid 
tissue (GALT) and Peyer’s patches (Figure 5e and f). This result is supported by previous 
findings showing a crucial role for TCF-1 in thymocyte development (187). As with TCF-1, we 
also detected LEF expression in intestinal polyps, although in normal epithelium, LEF transcripts 
were absent (Figure 5h).  Similar findings were observed in human colorectal tumours, in which 
case LEF expression is directly regulated by TCF-4/β-catenin (146). Lastly, we also examined 
expression of TCF-3.  Northern blot analysis has shown that TCF-3 is mainly expressed in the 
caudal portion of the intestinal tract (195).   Likewise, our analysis revealed expression of TCF-3 
in proliferative compartment of the colon, although we were unable to detect TCF-3 elsewhere 
(Figure 5i).  
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Discussion 
 
 In this paper we present an exhaustive overview of the expression pattern of Wnt 
signaling components in the murine intestine. As summarized in Figure 6 and Supplementary 
Table I (http://www.niob.knaw.nl/researchpages/clevers/files), Wnts and their downstream 
effectors are confined to specific mesenchymal and epithelial compartments of the intestine.  
Given these observations the function of at least some of these factors may be inferred.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Summary of expression data.  
Panels A and B show schematic representations of the small intestine and colon, respectively. The epithelium is 
shown in yellow while the mesenchymal layer is depicted in grey. Epithelial compartments associated with 
proliferation and differentiation are also shown. For simplicity only the expression pattern of Wnt signaling 
components which are most relevant to epithelial proliferation/differentiation are shown.  Factors highlighted in 
red are also upregulated in adenomas. Other factors such as WIF, Dkk-2 and LEF are not expressed in the normal 
intestine but are ectopically expressed in adenomas.  
 
 
Canonical and non-canonical Wnt signaling in the gut 
 In Figure 1 we have shown that in the small intestine Wnt-3 and Wnt-9b are expressed 
in Paneth cells. In Paneth cells nuclear β-Catenin is readily detected and is thought to activate 
expression of the repulsion/guidance receptor EphB3 (86).   EphB3 in combination with its 
ligand ephrin B1 force Paneth cells to occupy the very bottom of the crypts. Therefore, based 
on this evidence, Wnt-3 and Wnt-9b may act in an autocrine loop to activate TCF/β-catenin 
target genes involved in positioning of Paneth cells within the crypt-villus axis.  Wnt-3 and 
Wnt-9b may also be important in promoting maturation of Paneth cells. We and others have 
recently shown that expression of Paneth cell markers, such as anti-microbial peptides (i.e. 
cryptdins and defensins), is dependent on active Wnt/β-catenin signals (102;103).  
 
 Alternatively, Wnt-3 and 9b, as well as Wnt-6 expressed in crypt cells, may signal to 
epithelial progenitor cells lying above Paneth cells.  In turn, these canonical Wnts would drive 
proliferation, possibly through receptors identified here, such as Fz-5, Fz-7, and LRPs (Figure 3). 
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Along the same lines, recent immunohistological studies and in vitro functional assays have 
identified Wnt-11 as another candidate implicated in promoting proliferation (229). 
  
 Contrary to the Wnts discussed above, our study has also identified candidate Wnts 
likely involved in inducing non-canonical signals such as Wnt-2b, Wnt-4, Wnt-5a and Wnt-
5b.  These Wnts are expressed in the villus mesenchyme in the small intestine and/or the 
mesenchyme adjacent to the surface epithelium in the colon (Figure 2). In these regions, 
epithelial and mesenchymal cells are devoid of nuclear β-catenin and TCF target genes are 
turned off, implying that the above Wnts do not activate β-catenin/Tcf  in the intestine (230).   
Several lines of evidence suggest that non-canonical Wnt signals regulate a complex array of 
cellular responses including increased calcium flux, repression of TCF-mediated transcription 
and cytoskeletal rearrangements (25;211). Therefore, in the intestine Wnt-2b, Wnt-4, Wnt-5a, 
Wnt-5b could conceivably inhibit proliferation and promote differentiation of epithelial cells, 
induce cellular polarity and promote villus formation. The expression pattern of Wnt-5a in the 
gut combined with recent functional analysis illustrates this point particularly well. Indeed, 
experiments in transfected cells and Wnt-5a deficient limb buds have shown that Wnt-5a 
promotes degradation of β-catenin and suppresses TCF-activated genes (231). In the fetal gut 
and adenomas, Wnt-5a is expressed in mesenchymal cells closely associated with highly 
proliferative epithelial cells. Thus in this context, Wnt-5a may function to down-regulate β-
catenin and in turn attenuate proliferation.   
  
 The actions of non-canonical Wnts discussed above may be mediated by Fz-4 and Fz-6.  
Indeed, both receptors are expressed in the differentiated epithelial cells of the villi, in close 
proximity to Wnt-2b, Wnt-4, Wnt-5a and Wnt-5b-producing cells (Figure 3). Similarly in 
adenomas, Fz-4 and Wnt-5a are upregulated in epithelial and stromal cells, respectively. 
Considering that Fz-4 is known to physically interact with Wnt-5a (32), these factors may 
coordinate cross-talk between epithelial and mesenchymal cells. Finally, functional and 
biochemical evidence suggest that Fz-6 is an important mediator of planar cell polarity signals in 
mammalian epithelial cells (232) and can actively repress canonical Wnt signals (233). 
 
Factors modulating Wnt signaling in the intestine 
 Wnt signaling in self-renewing tissues such as the intestine is likely to be tightly 
regulated. Our screen of secreted Wnt antagonists has identified several factors, which may 
fulfill this function. sFRP-1, for example, was localized to the crypt mesenchyme, co-expressed 
and adjacent to cells abundantly expressing Wnts (Figure 4).  Consequently, sFRP-1 may 
function to modulate the effects of Wnt signaling in these regions. Indeed, a recent survey 
revealed that sFRP-1 was frequently downregulated in colorectal cancers, implying a tumour 
suppressor role for this factor (151). Moreover, forced expression of sFRPs block proliferation of 
colorectal cell lines (234). Similarly, WIF, as well as Dkk-2 and Dkk-3 may also play a role in 
tumorigenesis based on their ectopic expression in adenomas (Figure 4). However, how these 
factors may be implicated in adenoma formation is unclear, given that Wnt signaling is 
constitutively turned on in these cells. Further complicating the matter, in vivo data has shown 
that Dkk-3 is unable to block Wnt signaling (235;236); whereas Dkk-2 can synergize with Fz 
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receptors to induce Wnt signaling responses (237;238). Finally, sFRP-5 was strongly expressed 
in single epithelial cells of the bottom of crypts (Figure 4 and Supplementary Figure 2). Labeling 
experiments have shown that stems cells, the number of which may vary from 1-6 per crypt are 
located in equivalent positions just above the Paneth cells in the small intestine and at the crypt 
base in the colon (64;223;224).  We are presently investigating whether sFRP-5 positive cells 
represent bonefide stem cells by gene deletion in the mouse germ line.  
 
Diverse functions for TCFs in the gut 
 In this manuscript we have identified several, previously unknown, sites within the 
intestinal mucosa harboring TCF family members. TCF-1, for example, is proposed to 
function as a tumour suppressor regulating proliferation of epithelial cells in the intestine 
(145). This is confirmed by our ISH data, which also point to a possible role for TCF-1 in gut 
lymphocytes.  Similarly, the expression of TCF-4 in cellular compartments other than 
epithelial progenitors, such as the enteric nervous system and mature enterocytes (Figure 5), 
suggests a broader role for TCF-4 in the gut. This notion is particularly evident in the colon 
where TCF-4 was found mainly in differentiated cell types. In several systems TCF 
transcription factors are known to both activate and repress transcription (239). Accordingly 
TCF-4, in differentiated, β-catenin inactive cells, may be required to suppress target genes 
associated with proliferation.  On the other hand, Tcf-4 is also likely to play a role in 
maintaining proliferation of colonocytes. This assertion is based on the observation that in 
Tcf-4-/- embryos proliferative epithelial cells are absent in the proximal portion of the colon 
(data not shown).  The detection of TCF-3 in the colon in an inverse gradient to that of TCF-
4, also poses an interesting question.  Given the genetic data showing that TCF-3 primarily 
functions as a transcriptional repressor (179), it will be interesting to ascertain the role of 
TCF-3 in relation to TCF-4 in the colon.  
 
 In conclusion, our comprehensive overview of Wnt signaling in the intestine has 
identified for the first time specific Wnts and downstream signaling components likely involved 
in controlling both canonical and non-canonical pathways. In turn, this study reveals a broad role 
for Wnt signaling in regulating multiple aspects of intestinal development, homeostasis and 
cancerogenesis.   
 
 
Material and Methods 
 
-Probes 
 The following probes utilized in this study were described elsewhere. Wnt-1 (86;180); 
Wnt-2, Wnt-4, Wnt-5b, Wnt-6, Wnt-7a, Wnt-7b (205); Wnt-3, Wnt-3a (240); Wnt-8a (241); 
Wnt-8b (241;242); Wnt-9a/14, Wnt-9b/14b (242;243); Wnt-10a, Wnt-10b (244); Wnt-11 
(245); Fz-4 , Fz-7 (246); Dkk-1 (247), Lef (194).  Other probes were derived from RT-PCR 
products and correspond to the following nucleotides: 781-1640 for Wnt-16; for 1488-1815 
for Fz-1, for 1245-1784 Fz-2; for 1371-1733 Fz-3; 1500-2500 for Fz-5;  for 418-940 Fz-8; for 
1296-1864 Fz-9; for 994-1413 Fz-10. The remaining probes correspond to ESTs obtained 
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from the IMAGE consortium. The Genbank accession numbers for these probes are the 
following: Wnt-5a (4317623), Fz-6 (4973661), sFRP-1 (BG975485), sFRP-2 (BQ958218), 
sFRP-3 (AA399912), sFRP-4 (BC034853), sFRP-5 (BC032921), Dkk-2 (BE310466), Dkk-3 
(BQ933260), Dkk-4 (BC018400), WIF (BG246236), Cerberus  (AA120122), TCF-4 
(BG921346), TCF-1 (BF141520) and TCF-3 (AA015280).  To insure the specificity of the 
probes we generated both sense and anti-sense probes for Wnt-3, Wnt-9b, Wnt-4, Wnt5b, Wnt-
6, Fz-4, Fz-6, sFRP-1, sFRP-5, WIF, Dkk-2, Dkk-3, TCF-4, TCF-1, TCF-3 and tested these in 
parallel in our in situ hybridization protocol. Representative examples are shown in 
Supplementary Figure 1 (see http://www.niob.knaw.nl/researchpages/clevers/files).  
-In situ hybridization  
 Intestines from normal or APCmin mice (C57Bl6, 3 months of age) were flushed and 
fixed overnight in Formalin.  Samples were then dehydrated and embedded in paraffin, 
sectioned at 8µM and processed for hybridization as described below. Sections were 
dewaxed, rehydrated, treated with 0.2N HCL, digested in proteinase K solution, post-fixed, 
treated in acetic anhydride solution and hybridized overnight for 24-48hrs at 68°C with 
various probes in 5X SSC (pH 4.5), 50% Formamide, 2% Blocking Powder (Roche), 5mM 
EDTA, 50µg/ml yeast tRNA, 0.1% Tween 20, 0.05%CHAPS and 50µg/ml Heparin. Sections 
were then rinsed in 2X SSC and washed for 3X 20minutes at either 60 or 65°C in 2X 
SSC/50% Formamide. Following several rinses in TBST, sections were then blocked for 1/2 
hour in TBST containing 0.5% Blocking Powder (Roche). Next, sections were incubated in 
blocking solution overnight at 4°C with alkaline phosphatase-conjugated anti-digoxigenin 
(1/2000 dilution) (Roche). After washing several times in TBST, the color reaction was 
performed with NBT/BCIP solution.  For image analysis, sections were temporally mounted 
in glycerol or permanently mounted after dehydration in Pertex. A complete protocol will be 
provided upon request. In vitro transcription reactions to generate labeled probe was performed 
as follows: 1µg of linearized DNA was incubated at 37°C for more than 2 hours with 4 µl 
transcription buffer (Promega), 2 µl of DTT 0.1M (Promega), 2 µl of Dig RNA labeling mix 
(Roche), 1 µl RNAse inhibitor (Promega) and 1.5 µl of T7 or T3 or SP6 (Promega) in a total 
volume of 20 µl. 
 
-Antibody staining 
 Immunohistochemistry procedure is described elsewhere (86). Briefly, sections were 
pretreated with peroxidase blocking buffer (120 mM Na2HPO4, 43 mM citric acid, 30 mM 
NaN3, 0.2% H2O2; pH 5.8) for 20 minutes at room temperature. Antigen retrieval was 
performed by boiling samples in Na-citrate buffer (10 mM, pH 6.0). After 20 minutes, the 
boiling pan was allowed to slowly cool down to room temperature. Incubation of antibodies 
was performed in 1% BSA in PBS overnight at 4°C. The primary antibodies used in this study 
were rabbit anti-lysozyme (1:500; DAKO) and goat anti-TCF-4 (1:500; Santa Cruz). Rabbit 
anti-goat (DAKO) and rabbit EnVision+ (DAKO) were used as secondary antibodies. 
58 
   
 
 
 
CHAPTER 4 
 
 
 
 
 
Wnt signaling induces maturation of Paneth cells in 
intestinal crypts. 
 
 
 
 
 
 
 
Nature Cell Biology 7(4):381-386 (2005) 
 
  
 
 Chapter 4  
Wnt signaling induces maturation of Paneth cells in intestinal crypts. 
Johan H. van Es 1, 5, Philippe Jay 2, 5, Alex Gregorieff 1, 5, Marielle E.van Gijn 1, 
Suzanne Jonkheer 1, Pantelis Hatzis 1, Andrea Thiele 1, Maaike van den Born 1, 
Harry Begthel 1, Thomas Brabletz 3, Mark M. Taketo 4 and Hans Clevers 1. 
 
1  Hubrecht Institute, Netherlands Institute for Developmental Biology, Uppsalalaan 8,  3584CT Utrecht, the 
Netherlands. 
2  Present address, Institut de Génétique Humaine (IGH), CNRS UPR 1142, 141, rue de la Cardonille, 34396 
Montpellier cedex 5, France. 
3 University of Erlangen, Dept. of Pathology, Krankenhaustr. 8-10, 91054 Erlangen, Germany. 
4  Department of Pharmacology, Kyoto University Graduate School of Medicine, Yoshida-Konoé-cho, Sakyo-
ku, Kyoto 606-8501, Japan. 
5 These authors made an equal contribution. 
 
 
 
 
 
 
Abstract 
 
 Wnt signaling, transduced through β-catenin/Tcf4, maintains the undifferentiated state 
of intestinal crypt progenitor cells. Mutational activation of the pathway initiates the 
adenoma-carcinoma sequence. While all other differentiated epithelial cells migrate from the 
crypt onto the villus, Paneth cells home towards the source of Wnt signals, i.e. the crypt 
bottom. We find that expression of a Paneth gene program is critically dependent on Tcf4 in 
embryonic intestine. Moreover, conditional deletion of the Wnt receptor Frizzled-5 abrogates 
expression of these genes in Paneth cells in the adult intestine. Conversely, adenomas in APC 
mutant mice and colorectal cancers in man inappropriately express these Paneth cell genes. 
These observations imply that Wnt signals in the crypt can separately drive a stem-
cell/progenitor gene program and a Paneth cell maturation program. In intestinal cancer, both 
gene programs are activated simultaneously.   
 
 
 
 
 
 
 
 
 
61 
Wnts induce Paneth cell maturation  
 Wnt signaling plays a key role in the intestinal epithelium (87). Central to this 
signaling pathway is the stabilization of β-catenin and its interaction with TCF transcription 
factors within the nucleus (39;40). Cytosolic levels of β-catenin are tightly regulated. In the 
absence of Wnt signals, a dedicated complex of proteins including APC, Axin and GSK3-β 
phosphorylates β-catenin, resulting in its ubiquitination and degradation by the proteasome 
(248;249). Signaling by Wnt factors inhibits the APC complex. As a result, β-catenin is 
stabilized and translocates into the nucleus where it interacts with nuclear Tcf transcription 
factors to drive the transcription of specific target genes (39;40). Mutational activation of the 
Wnt signaling pathway in intestinal epithelial cells inappropriately activates Tcf4 and initiates 
adenoma formation (10;11). We have recently determined the Tcf4 target gene program in 
colorectal cancer cells and have found that it is physiologically expressed in the proliferative 
crypt progenitors of the intestinal epithelium (69). As an integral part of this program, 
β-catenin and Tcf4 control expression of EphB cell sorting-receptors. These receptors allow 
the correct positioning of epithelial cells in a Wnt gradient along the crypt-villus axis (86). 
  
 
Figure 1. Cryptdins are target genes of the Tcf4-β-catenin signaling pathway. 
Cryptdin-1 and Cryptdin-6 mRNA is readily detectable in the small intestine of Tcf4+/- E14.5 embryos (A, C), 
but is absent in Tcf4-/- embryos (B, D). No differences in proliferation were noted at E14.5 between Tcf4+/- and 
Tcf4-/- intestines as revealed by immunostaining for the proliferation marker Ki67 (E and F respectively).  
 
 Late embryonic mice deficient for the Tcf4 transcription factor fail to maintain the 
epithelial stem-cell compartments in the intervillus pockets of the small intestine (66). We 
utilized this genetic model to ask, by DNA array analysis, which genes are regulated by Tcf4 
in the developing intestine. To this end, we compared expression profiles of Tcf4-/- and Tcf4+/- 
small intestines at E15.5, E16.5, and E18.5. As predicted, we identified multiple Tcf4 target 
genes (e.g. Myb, c-Myc, GPX-2, CDX-1) that were previously defined by inducibly blocking 
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the Wnt cascade in human colorectal cancer cell lines (69). Remarkably however, of the top-
50 down-regulated genes, at least 8 encoded Paneth cell markers including several Cryptdins, 
Peptidoglycan Recognition Protein (PGRP) and Mpgc60 (see online version for 
Supplementary information, Table S1) (250-252). We realized that two previously published 
Tcf4 target genes in colorectal cancer cells, MMP7/Matrilysin (253) and EphB3 (86), also 
represent Paneth cell markers.  
 Paneth cells, which physically appear two weeks after birth, localize to the base of the 
crypts of Lieberkühn. They contain large apical secretory granules filled with a diverse array 
of antimicrobial proteins and peptides, including lysozyme and Cryptdins (254). The mouse 
Cryptdin gene family encodes at least 19 different Cryptdin proteins (255). In the small 
intestine, the Cryptdin-1 to -6 peptides are specific to Paneth cells (255). Cryptdin precursors 
are processed and activated in Paneth cells by the matrix metalloproteinase MMP-7 (256). 
Indeed, MMP-7-deficient mice do not process procryptdin precursors, resulting in a lack of 
mature Cryptdins and a defect in clearing intestinal infections (257). Below, we refer to the 
Tcf4-driven Paneth cell program as the MMP-7/Cryptdin program.  
 Despite the fact that Paneth cells are morphologically absent in embryonic and 
neonatal mice, the analyzed Cryptdin-1 and -6 mRNAs were readily detectable in the small 
intestine of TCF4+/- E14.5 embryos (Fig. 1A, 1C), yet absent from the small intestines of 
Tcf4-/- E14.5 embryos (Fig. 1B, 1D). Of note, the previously described Tcf4-/- phenotype, i.e. 
the abrogation of proliferation in the small intestinal epithelium, first becomes evident at 
E16.5 (66). Indeed, no differences were observed in expression of the cell cycle marker Ki67 
at E14.5 (Fig. 1E, 1F).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Strong nuclear expression of β-catenin and Tcf4 in Paneth cells and the upregulation of Paneth 
cell specific genes in APCmin tumors. 
Immunohistochemical analysis revealed that the nuclei of Paneth cells contained high levels of the Wnt effectors 
Tcf4 (A) and β-catenin (B). In situ hybridization on the intestines of APCmin mice revealed that the Paneth cell 
genes MMP7 (C and (253)), EphB3 (D and (86)) Cryptdin-1 (E) and Cryptdin-6 (F) are inappropriately 
expressed in adenomas. Inserts show normal Paneth cell expression of these Wnt targets in the intestinal crypt. 
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We have previously shown that proliferative crypt cells accumulate nuclear Tcf4 and 
β-catenin, indicative of active Wnt signaling. Similar analyses revealed that the nuclei of 
Paneth cells contained even higher levels of both Wnt effectors (Fig. 2A and 2B). Moreover, 
adenomas in APC mutant mice inappropriately expressed the MMP-7/Cryptdin program, 
including the genes encoding MMP7, EphB3, Cryptdin-1 and Cryptdin-6 (Fig 2C-2F). In 
addition, DNA array analysis on human colorectal cancers revealed that in the majority of 
these colon tumors (6 out of 8), the human functional counterparts of the Paneth cell-specific 
Cryptdins, Defensin-5 and Defensin-6 were also highly up-regulated (28.0 and 44.5 times, 
respectively). 
 
The combined data suggested that the MMP-7/Cryptdin program contained direct Wnt 
target genes. We have previously determined a 12 bp optimal TCF binding site conserved 
from fly to man, AAGATCAAAGGG, where changes are tolerated in the first three bases 
only (258;259). Alignment of the promoters of murine Cryptdin-1, -2, -3, -5 and -6 revealed 
the complete conservation of a high-affinity TCF site, AAcATCAAAGGG (see 
Supplementary information Fig. S1). The promoters of human Defensin-5 and -6 also contain, 
at a conserved position, a high-affinity TCF-binding site fitting this consensus, 
AgcATCAAAGGG (see Supplementary information Fig. S1). A recent transgenic study has 
demonstrated that a 1402 bp promoter fragment of the human Defensin-5 gene faithfully 
drives Paneth-cell specific gene expression (260). A transient promoter assay demonstrated 
that this Defensin-5 promoter is indeed activated by β-catenin associated with endogenous 
Tcf through the conserved TCF site (Fig. 3A). The activation could be blocked by dominant-
negative Tcf4 (Fig. 3A), while mutation of the conserved Tcf binding site in the Defensin-5 
promoter also abrogated the activation by endogenous Tcf associated with β-catenin (Fig. 
3B). Similarly, the murine Cryptdin-1 and Cryptdin-6 promoter were activated by the β-
catenin/Tcf bipartite transactivation complex (Fig. 3C).  
 
Figure 3. Tcf/β-catenin 
activation of the Cryptdin-1, 
Cryptdin-6 and Defensin-5 
promoter through a highly 
conserved TCF binding site. 
Reporter construct containing 
deletions of the Paneth cell 
specific Defensin-5 promoter 
(260), containing a conserved 
TCF binding site 
(AAGATCAAAGGG) were 
generated. In a transient 
transfection assay, the 
Defensin-5 promoter constructs 
could be activated by an active 
Tcf/β-catenin bipartite 
transcription complex, which 
could be blocked by a 
dominant negative Tcf4 (A). 
The mutation of the highly 
conserved Tcf binding site (AAGATCCCCGGG) in the Defensin-5 promoter abrogated this Tcf/β-catenin 
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signaling (B). Reporter constructs of Defensin-5, Cryptdin-1 and Cryptdin-6 containing the highly conserved 
TCF binding site, could be activated by an active Tcf/β-catenin bipartite transcription complex (C). Chromatin 
immunoprecipitation analysis of the Cryptdin-1 and Cryptdin-6 promoters in Paneth-cell enriched crypt fractions 
revealed the occupancy of β-catenin. Bars represent Real-Time PCR values obtained with primers spanning the 
respective promoters normalized to the inputs and values obtained with primers spanning a control region 
downstream of the Cryptdin-6 gene, which was set to 1 for each calculation.  
 
We also performed chromatin immunoprecipitations with an antibody directed against β-
catenin on isolated mouse crypts (261). The results unambiguously demonstrated the presence 
of β-catenin on the promoters of Cryptdin-1 and -6 (Fig. 3), confirming the notion that these 
genes represent direct Wnt targets. 
 
Independent of these experiments, we analyzed mRNA expression of all Frizzled 
family members in fetal and adult intestine by Northern blotting and in situ hybridization 
(A.G., submitted). In adult small intestine, we detected crypt-specific expression of 3 Wnt 
genes (Wnt3, and Wnt9b). Moreover, Frizzled5 (Fz5) and Frizzled6 were prominently 
expressed in small intestinal epithelium. Interestingly, Frizzled6 was expressed by all 
epithelial cells with the exception of Paneth cells, while Fz5 was expressed by all cells in the 
crypt. Fz5-/- embryos die in utero around E10 due to defects in yolk sac and placental 
angiogenesis (262). To analyze the function of Fz5 in the adult intestine, we created a mutant 
Fz5 allele, in which the single exon-open reading frame was sandwiched by LoxP sequences 
(see Supplementary information Fig. S2). We then generated germline chimeras and crossed 
their offspring with the intestine-specific K19-Cre knock-in mouse (263). The K19-Cre allele 
is expressed in a somewhat mosaic pattern throughout the intestinal epithelium from early 
stages of embryonic development into adult life (263). This was confirmed by the generation 
and subsequent analysis of a K19-LacZ knock-in mouse. This analysis revealed patchy 
expression of LacZ along the gastrointestinal tract (see Supplementary information Fig. S3). 
The expression of LacZ was highest in the duodenum and gradually declined along the 
gastrointestinal tract towards the rectum.  
 
 Fz5LoxP/LoxPK19-Cre mice were healthy and fertile. Histological analyses of the entire 
gastrointestinal tract revealed a single abnormality. While the proliferative crypt compartment 
was intact, Paneth cells were randomly distributed in crypts and villi, as evidenced by 
morphology and by the markers lysozyme (Fig. 4D), FAS ligand (Fig 4E) and staining for 
Zinc-positive granules by the pholoxine tartrazine technique of Lendrum (Fig. 4E) 
(254;264;265). The highest number of miss-positioned Paneth cells occurred in the duodenum 
(not shown), coinciding with the expression of the Cre enzyme. The phenotype of miss-
positioned Paneth cells was indistinguishable from that of EphB3-/- mice (86). Indeed, the 
miss-positioned Paneth cells of the Fz5LoxP/LoxPK19-Cre mice never expressed the Tcf4 target 
gene EphB3, while the crypt Paneth cells did express EphB3 (Fig. 4G), providing an 
explanation for the observed miss-positioning and confirming our notion that the Wnt cascade 
provides positional clues along the crypt/villus axis (86). The miss-positioned Paneth cells 
appeared immature, based on the small size of their granules relative to those of Paneth cells 
in the crypts. These observations suggested that Fz5 plays a non-redundant role in the 
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transduction of canonical Wnt signals in the Paneth cell maturational process. Indeed, the 
miss-positioned Paneth cells displayed a complete absence of nuclear β-catenin (Fig. 4H). In 
situ hybridization revealed the absence of Cryptdin-1 mRNA in miss-positioned Paneth cells 
(Fig. 4L). Of note, the expression of the Tcf4-independent Paneth cell markers lysozyme 
remained unchanged, allowing for unambiguous identification of the Paneth cells (Fig. 4C, 
4D, 4I, 4G and 4K resp.). In crypts of Fz5LoxP/LoxP-K19Cre mice, some Paneth cells remained 
at the crypt base and expressed targets of the Wnt pathway. We reasoned that this resulted 
from the inefficiency of Cre-mediated deletion, due to the mosaic expression pattern of the 
Cre enzyme in these mice (263). Indeed, staining of the intestine derived from the 
Fz5LoxP/LoxP-K19Cre mice revealed the presence of Fz5 expressing Paneth cells in the crypt, 
while all miss-positioned Paneth cells were Fz5-negative (Fig. 4F). In conclusion, the Wnt 
signaling pathway activates the MMP-7/Cryptdin maturation program in Paneth cells through 
the Fz5 receptor. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Paneth cells in the small intestine of Fz5LoxP/LoxP K19-Cre mice. 
In situ hybridization with a Fz5 probe revealed that Fz5 is expressed in the (developing) crypts of neonatal (A) 
and adult mice (B). Staining of the intestine derived from Fz5LoxP/LoxP mice (C) and Fz5LoxP/LoxP K19-Cre mice (D-
L). The panels G and H; I and J; and K and L represent three sets of serial sections. The panels C, D, G, I and K 
were stained with an antibody directed against lysozyme. Panel E were stained with an antibody directed against 
the FASligand and stained for Zn, Panel F with an antibody directed against Fz5, Panel H with an antibody 
directed against EphB3, Panel J with an antibody directed against β-catenin, and panel L with an in situ probe 
directed against Cryptdin-1. The Paneth cells of the Fz5LoxP/LoxP K19-Cre mice, in sharp contrast to the Paneth 
cells of Fz5LoxP/LoxP mice (C), stray from the crypt (B). Panel E shows that the mislocoalized Lysozyme positive 
cells also stained for the Fas ligand and contains Zinc-positivity of cytoplasmic granules. These markers 
unequivocally identify the mislocalized cells as Paneth cells. Panel shows that the mislocalized Paneth cells do 
not express Fz5, while the Paneth cells which stay at the bottom still express Fz5. The miss-positioned Paneth 
cells express the Paneth cell marker lysozyme (G, I, K), but lack expression of the Wnt signal transducer nuclear 
66 
 Chapter 4  
β-catenin (J) or the Wnt target genes EphB3 (H), Cryptdin-1 (L) or Cryptdin-6 (results not shown). Insets in J 
show that the Paneth cells in the crypt do contain β-catenin in the nucleus (bottom left), whereas miss-positioned 
Paneth cells do not have nuclear β-catenin (top right). 
 
 
The canonical Wnt signaling cascade is known to control multiple biological phenomena in 
vertebrates and model organisms, involving either cell fate determination or maintenance of 
stem/progenitor cells in compartments with predefined fates (64;174;266;267). A recent 
example of the latter is the role of Wnt signaling in the hematopoietic stem cell (268). The 
effect of Wnt signaling on Paneth cell maturation described here contrasts with this paradigm. 
In the absence of Wnt signals, Paneth cells are correctly specified, but fail to express the 
MMP-7/Cryptdin program. As a consequence, these postmitotic cells do not undergo 
morphological maturation. This adds a twist to the central role that the Wnt cascade plays in 
the biology of the crypt. Wnt signals near the bottom of crypts are crucial for the maintenance 
of the undifferentiated progenitors. Postmitotic immature Paneth cells, once specified, appear 
to utilize Wnt signals for the opposite aim: to reach full maturity through the Wnt-induced 
expression of the MMP-7/Cryptdin program.  
 
Methods. 
DNA array analysis. 
 DNA array analysis of mouse embryos. Total RNA was isolated from small intestine 
of Tcf4+/- and Tcf4-/- embryos (E15.5, E16.5 and E18.5) using TRIzol Reagent (Gibco BRL 
Life Technologies). cDNA synthesis and labeling were performed according to Affymetrix 
guidelines. Samples were hybridized on Murine Genome U74 arrays (Affymetrix) 
representing 36.000 full length genes and ESTs. Overall fluorescence for each GeneChip was 
scaled to a target intensity of 200 and pairwise comparisons were performed with Affymetrix 
MICROARRAY SUITE. Genes were selected based on the following criteria. For each time 
point, GeneChips for Tcf4 wt intestines were designated as baseline and all mRNAs which 
were decreased in Tcf4-/- intestines more than 1.5 fold in two out of three time points were 
selected.  
 DNA array analysis of human tumors. Detailed protocols and results will be published 
elsewhere (Hlubek et al., manuscript in preparation). In brief total RNA was separately 
prepared from eight microdissected human colorectal carcinomas and normal mucosa. Probe 
labelling and hybridisation to Affymetrix U133A arrays, representing 14,500 genes, were 
performed according to the Affymetrix guidelines (Affymetrix, Santa Clara, CA). The arrays 
include a set of human maintenance genes (> 100 probe sets) to facilitate the normalization 
and scaling of detected fluorescence values. This set of genes served as a tool to normalize 
expression levels, and allowed quantitative comparison of different tissues. Mean expression 
values of 8 tumours and normal colon mucosa were used to calculate the tumour/normal ratio 
of the selected genes.  
 
Promoter analysis. 
Schematic of the Defensin-5 deletion promoter constructs cloned in Pgl3basic 
(Promega). HEK293T cells were cotransfected with 500 ng of the indicated HD-5 promoter 
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constructs and/or plus 10 ng S33β-catenin expression vector and/or 500 ng of a DN-Tcf4 
expression vector and 50 ng of TK-Renilla reporter vector using Fugene (Roche). Total 
amounts of plasmid were kept constant by adding the empty DNA vector. The assays were 
harvested 20 hours later to assess luciferase and renilla activity using the dual-luciferase 
reporter assay (Promega). The assays were performed in triplicate and repeated at least three 
times.  Data reported are normalized for transfection efficiency. 
 
Chromatin Immunoprecipitation analysis on isolated crypts. 
 The Paneth-cell enriched crypt fractions were cross-linked with 1% formaldehyde for 
10 min at room temperature, with gentle agitation. Cross-linking was terminated by the 
addition of glycine to a final concentration of 0.125M. The cells were washed twice with ice-
cold PBS and swelled on ice for 10 min in 25 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM 
KCl, 0.5% NP40, 1 mM DTT and protease inhibitor cocktail (Roche). After Dounce 
homogenization the nuclei were resuspended in sonication buffer containing 50 mM HEPES 
(pH 7.9), 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.5% SDS 
and protease inhibitors, sonicated for 4 min with 30 sec on and 2 min off cycles at high 
settings in a Diagenode Bioruptor to produce fragments with an average length of 400 bp. The 
chromatin was centrifuged, adjusted to 0.1% SDS, precleared and subjected to 
immunoprecipitation as described (261), with an antibody directed against β-catenin (BD 
Transduction Laboratories). The DNA in the immunoprecipitates was analyzed in 
SYBRGreen Real-Time PCR reactions on a MyiQ apparatus (Bio-Rad). The primers used for 
the PCR amplifications were the following: Cryptdin-1 promoter, sense: 5’-
GGGAAATGGGAGTAGACTGAAG-3’ and antisense: 5’-
GGAAGTTGGAGAGGCTGTTAC-3’, Cryptdin-6 promoter, sense: 5’-GATGGGAA 
ATGGGAGAAGACTG-3’ and antisense: 5’-GGGAAGTTGGAAAGGGTGTTAC-3’, 
control region downstream Cryptdin-6, sense: 5’-GCCATTCGGATGTTCACTCTG-3’ and 
antisense: 5’- TCGTCTTGACCAACTGTTCT TG-3’. 
 
Generation of the Cre inducible Fz5 KO mouse.  
 A P1 clone containing the mouse Fz5 gene was isolated from a mouse genomic 
library. The Fz5 coding region was PCR amplified (5'cgg gat cca gta ctg aat tcg ggc gtc aca 
ctc aag act cc3' and 5'cgc gga tcc aac agt aac ctc att aca atg cc3') and cloned between 2 LoxP 
sites of the modified pFlox vector. The 1 Kb 3’arm was subsequently cloned, followed by 
cloning of the 2.5 Kb 5’ arm. Details of this construct are available on request. The construct 
was linearized and electroporated into E14 ES cells. Approximately 300 ES cell clones 
selected by neomycine (250 µg ml) were screened by Southern-blot analysis for the presence 
of a recombinant 2.4-kb EcoRI band, in addition to the endogenous 4.5-Kb fragment. A 350 
bp PCR amplified fragment was used a probe (5'gat act agc acg tct gtc acc3’ and 5'ccc cgc 
ggc ccc gcc cgg ag3'). Four out of 300 ES cell clones analyzed had undergone correct 
integrations at both ends of the construct. Chimaeric mice were derived from two randomly 
chosen clones; both transmitted the mutation through the germline.     
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Tissue sample preparation, immunohistochemistry and in situ hybridisation. 
 The intestinal tract was dissected as a whole and flushed gently with cold PBS to 
remove any faecal content. The small intestine was rolled up into a compact circle and fixed 
in Formalin at RT for 16 hours. The tissues were sectioned (2–6 µm). Following dewaxing 
and hydration, sections were pretreated with peroxidase blocking buffer (120 mM Na2HPO4, 
43 mM citric acid, 30 mM NaN3, 0.2% H2O2; pH 5.8) for 15 minutes at room temperature. 
Antigen retrieval was performed by boiling samples in Na-citrate buffer (10 mM, pH 6.0). 
After 20 minutes, the boiling pan was allowed to slowly cool down to room temperature. 
Incubation of antibodies was performed in BSA in PBS overnight at 4°C for antibodies 
directed against Cryptdin, Tcf4, Fz5 and MMP-7 and at RT for 1 hour for antibodies directed 
against lysozyme and Ki67. In all cases, the Envision+ kit (DAKO) was used as a secondary 
reagent. The incubation time was 30 min. For goat antibodies, a bridge step using rabbit anti-
goat antibodies was required. Stainings were developed using DAB. Slides were then 
counterstained with hematoxylin and mounted. The Fixation and staining of sections used for 
β-catenin and EphB3 expression was exactly as described (86). The following antibodies were 
used. Goat anti-EphB3 (1:100; R&D systems), Rabbit anti-lysozyme (1:1500; DAKO), 
Mouse anti-Ki67 (1:100; Novocastra), and mouse anti-β-catenin (1:50; Transduction Labs), 
Mouse anti-Tcf4 (1:400; Signal Transduction Lab), Goat anti-MMP-7 (1:50; R&D systems), 
Rabbit anti-Cryptdin-1 (1:1500; kind gift of Dr. Ouellette (269)),  Rabbit anti-Frizzled5 
(1:100; Upstate). In situ hybridizations were performed as described (270). As a probe for 
Cryptdin-1 and -6 we used anti-sense RNA derived from the Image clones 1096215 and 
1545534 resp.  
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Abstract 
 
In the intestinal epithelium, the Wnt cascade promotes cycling of progenitor cells and 
concomitantly drives maturation of secretory cell lineages. Despite this knowledge, the 
precise mechanism by which Wnt signaling coordinates both proliferation and differentiation 
of gut epithelial cells has remained largely unexplored. To gain insight into the dual role of 
Wnt signaling, we examined the gene expression profiles of wild-type vs Tcf4-/- fetal guts. In 
Tcf4 deficient intestines, we found specific upregulation of enterocytic markers (ie. Fabp1, 
Creb3l3, Nr1h4, etc.) along with downregulation of secretory lineage markers (ie. Tff3, 
Chromogranin B, and Spink4, etc.) and crypt progenitor markers (ie. c-Myc, c-Myb, TcfAP4, 
etc).  Further analysis suggested that Tcf4 promotes early commitment of secretory lineages 
through activation of the basic helix-loop-helix transcription factor, Math1. Moreover we 
found that Tcf4-mediated effects on cell fate were independent of any changes in the 
expression of Hes family members. Finally our results imply a model whereby Tcf4 
coordinates renewal of progenitor cells, repression of enterocyte differentiation and 
commitment towards secretory lineages via Math1. 
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Introduction 
 
The intestinal epithelium is an ideal model system in which to dissect the mechanisms 
regulating epithelial cell proliferation and differentiation (271). The proliferative 
compartment of the gut epithelium is composed of a population of multipotent progenitor 
cells. In the adult intestine, progenitor cells reside in the crypts of Lieberkühn, while in the 
fetal intestine these cells occupy so-called intervillus pockets. As progenitor cells mature they 
give rise to two differentiated lineages, absorptive and secretory cells.  The absorptive lineage 
or enterocytes functions in nutrient uptake and comprise the vast majority of epithelial cells 
lining the intestine. The secretory lineage can be divided into cells producing: mucus 
(i.e.goblet cells), hormones (ie. enteroendocrine cells) and anti-microbial peptides (ie. Paneth 
cells). Most differentiated cell types cover the finger-like projections termed villi. One notable 
exception to this rule includes the Paneth cells, which complete their differentiation program 
at the very bottom of the crypts. 
 
The self-renewing capacity of the intestinal epithelium strongly depends on continual 
activation of the Wnt cascade. Secreted Wnt factors induce their biological effects in part by 
triggering the release of β-catenin from a destruction complex comprised of APC, GSK3β and 
Axin, which in the absence of Wnts, promotes ubiquitin-mediated degradation of β-catenin 
(for up-to-date reviews see www.stanford.edu/~rnusse/ wntwindow.html). Subsequently, β-
catenin translocates to the nucleus where it associates with members of the Tcf family of 
transcription factors (Tcf1, Tcf4, Tcf3 and Lef) and thereby activates transcription of target 
genes (39;40). Several in vivo models have highlighted the importance of Wnt signaling 
components in driving proliferation of the progenitor cells in the intestinal epithelium. 
Aberrant activation of the Wnt pathway through mutations in the genes encoding for APC, β-
catenin or Axin2 leads to hyperproliferation and ultimately colon cancer (9;11;73;128;129). 
Moreover, perturbed Wnt signaling resulting from inactivation of Tcf4, β-catenin or ectopic 
expression of the Wnt antagonist, Dkk-1 results in the loss of proliferative cells (65-68). 
 
Analysis of the above mouse models has also led to the notion that Wnts specifically 
promote the formation of secretory lineages (65;66;68). The earliest known determinant of 
secretory cells is the basic helix-loop-helix transcription factor Math1. Targeted deletion of 
Math1 results in a total loss of secretory cell types (95). Another key cell fate determinant in 
the intestine is the Notch target gene Hes1. Functional evidence from neuronal and intestinal 
cells indicates that Hes1 appears to block Math1 transcriptional activation and thereby skews 
progenitor cells away from secretory lineages. Indeed, inactivation of Hes1 results in a 
relative increase in the numbers of secretory cells when compared to enterocytes (96;98). 
Similarly, blockage of the Notch pathway (and presumably Hes1) results in a massive 
conversion of progenitor cells into postmitotic goblet cells (272;273); and conversly 
constitutive activation of the Notch receptor results in a perturbed production of secretory 
cells (274-276). It is currently unknown whether Wnt signaling promotes secretory lineage 
differentiation by modulating Math1/Hes1 activity or whether Wnts act via an independent 
mechanism. 
74 
 Chapter 5  
 
To assess how maintenance of progenitor cells and differentiation towards secretory 
cells types is controlled by Wnt signaling, we wished to identify and characterize Wnt 
responsive genes in the intestine. By DNA microarray analysis, we compared the gene 
expression profiles of wild-type and Tcf4 deficient fetal small intestines. Previously using this 
approach, we reported that Tcf4 regulates the expression of numerous Paneth cell markers 
including the anti-microbial peptides, cryptdins (103).  Herein, we present the complete list of 
Tcf4 responsive genes including novel crypt progenitor markers, as well as secretory cell and 
enterocytic markers. Finally, we propose a model whereby Tcf4 drives secretory lineage 
commitment through Math1 upregulation and actively represses enterocyte differentiation via 
a Hes1 independent mechanism. 
 
Materials and Methods 
 
Immunohistochemistry 
 
Fetal intestines were fixed overnight in 4% PFA at 4°C and adult intestines were fixed 
overnight in Formalin at room temperature. Samples were then dehydrated, embedded in 
paraffin and sectioned at 4µM. Antigen retrieval and antibody stainings were carried out as 
detailed in (277). The primary antibodies used in this study were mouse anti-Ki67 (1:100; 
Novocastra), rabbit anti-Math1 (1:50 dilution) and rabbit anti-synaptophysin (1:200 dilution; 
DAKO).  The EnVision+ system (DAKO) was used as a secondary antibody. 
 
In situ hybridization 
Intestines were fixed and embedded in paraffin and sectioned at 8µM. Sections were 
dewaxed, rehydrated, treated with 0.2N HCl, digested in proteinase K solution, post-fixed, 
treated in acetic anhydride solution and hybridized overnight for 24-48hrs at 68°C with 
various digoxigenin -labeled RNA probes in 5X SSC (pH 4.5), 50% Formamide, 2% 
Blocking Powder (Roche), 5mM EDTA, 50µg/ml yeast tRNA, 0.1% Tween 20, 0.05% 
CHAPS and 50µg/ml heparin. Sections were then rinsed in 2X SSC and washed for 3X 20 
minutes at either 60 or 65°C in 2X SSC/50% formamide. Following several rinses in TBST, 
sections were then blocked for 1/2 hour in TBST containing 0.5% Blocking Powder (Roche). 
Next, sections were incubated in blocking solution overnight at 4°C with alkaline 
phosphatase-conjugated anti-digoxigenin Fab fragments (1/2000 dilution) (Roche). After 
washing several times in TBST, the color reaction was performed with NBT/BCIP solution.  
For fluorescence in situ hybridization (FISH) sections were pretreated as above except for the 
following modifications. Sections were hybridized with a digoxigenin-labeled Tff3 probe and 
a FITC-labeled Spdef probe. Following post-hybridization washes sections were treated with 
peroxidase blocking buffer (1.5% H2O2 in PBS) for 30 minutes. Next, sections were blocked 
with 1% BSA in PBS for 30 minutes, followed by HRP-conjugated anti-FITC Fab fragments 
at room temperature for 2 hours (1:250) (Roche). Sections were washed 5X in PBS followed 
by treatments with Alexa Fluoro 488-labeled tyramide according to manufacturer’s 
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instructions (Molecular Probes). Following a second peroxidase blocking step, sections were 
incubated with HRP-conjugated anti-digoxigenin Fab fragements at room temperature for 2 
hours (1:250) (Roche).  After washes sections were treated with Alexa Fluoro 546-labeled 
tyramide. Stainings were visualized using sequential scanning with a Leica TCS SP2 AOBS 
confocal microscope. 
 
-Probes 
The following probes utilized in this study correspond to ESTs obtained from the IMAGE 
consortium. The Genbank accession numbers for these probes are the following: Vav3 
(BQ887952), Tcfap4 (BC047270), Nr1h4 (BG971664), FABP1 (BF384218), Creb3l3 
(BX521612), Tff3 (BC011042), Hop (BQ936961), Gob4 (BQ946802), Gob5 (BQ946441), 
Cholecystokinin (AI385905), Chromogranin B (BU503622), Spink4 (AA823442), c-Myc 
(BI080251), Spdef (BG916428), Klf4 (BI692353). The Hes1 probe was described elsewhere 
(278). 
 
-Microarrays 
Total RNA was isolated from whole small intestines of E15.5 wt, Tcf4+/- and Tcf4-/- 
embryos using TRIzol Reagent (Invitrogen, Carlsbad, CA). Pooled RNA derived from two 
wild-type or two Tcf4-/- littermates were compared in duplicate experiments. Sample pairs 
were also dye-swapped and processed at the same time. cDNA synthesis and Cy-3 and Cy-5 
labelings were performed using the Agilent low RNA input fluorescent linear amplification 
kits. Samples were hybridized on Whole Mouse Genome Oligo Microarrays (G4122A). 
Genes were selected based on the following criterion. All mRNAs that were decreased or 
increased by more than 1.5-fold in Tcf4-/- intestines in duplicate experiments were selected. 
The complete list of changed genes is available at: http://www.niob.knaw.nl/ researchpages/ 
clevers/files/Completelist.xls 
 
-RT-PCRs 
As for microarrays, total RNA was isolated from the small intestine of E15.5 wt, Tcf4+/- and 
Tcf4-/- embryos using TRIzol Reagent (Invitrogen, Carlsbad, CA). cDNA was synthesized 
from 0.5µg of total RNA using random hexomers. PCRs were performed with the following 
oligos: Hes1 (F: AACCTGCAGCGGGCGCAGATGAC,  
R: AATGGCGCGTGCTGGGGACCGG), Hes5 (F: GGCTCCCTCCTCCGGCTGGCT,  
R: CGGGCTGGGGTGAGCCAACCC), Hes6 (F: AGCCCCTGGTGGAGAAGAAGCGAC, 
R: TCGATGGCTTGGCACGTGGACACG), Hes7 (F: CCTCCGGAACCCGAAGCTGGA, 
R: CGGTAGCCGTGCAGCGCGGAG), Math1  
(F: TCGCACCGCCTCCTCCTATGAAG, R: AGAGTCACTGTAATGAGAGTGGGGGG), 
Ngn3 (F: GGAGCAGAGAGGCTCAGCTATCC, R: GTGCCAACTCGCTCTTGGGCCTG), 
Pax4 (F: GCGCAGGCAAGAGAAGCTGAAATG, R: GATGGCACTTGTCCTGGGCCTC), 
NeuroD (F: GGACACGAGGAATTCGCCCACGC, R: TGCCTCGTGTTCCTCGTCCTGA), 
beta-actin (F: AAGAGAGGCATCCTCACCCT, R: TACATGGCTGGGGTGTTGAA) 
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Results 
 
Loss of proliferative epithelial cells and secretory lineages in Tcf4-/- intestines 
Tcf4-/- mice die postnatally presumably due to their inability to maintain proliferative 
cells in the small intestine. As shown previously (66) and in Figure1, immunohistochemical 
analysis of the proliferation marker Ki67 revealed a severe impairment of epithelial cell 
proliferation in Tcf4-/- small intestines starting at E16.5. However, at earlier time-points 
(E14.5 and E15.5), proliferation within the epithelial appeared unaffected. Tcf4 mutants also 
displayed a drastic reduction in the numbers of enteroendocrine cells and goblet cells in the 
small intestine (Figure 1I-L). Although not morphologically evident until after birth, Paneth 
cells also appeared to be absent in Tcf4-/- intestines based on the analysis of Cryptdin-1 
expression (data not shown). Note however that upon closer examination goblet cells were 
apparent, albeit at reduced numbers, towards the most distal regions of the small intestine 
(data not shown). Similarly enteroendocrine cells were also detected near the gastro-duodenal 
junction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Loss of proliferative epithelial progenitors and secretory lineages in Tcf4-/-small intestines.  
Immunohistochemical analysis of proliferative cells, goblet cells and enteroendocrine cells at various 
developmental stages (E14-E18) in wild-type (A, C, E, G, I, K) and Tcf4-/- (B, D, F, H, J, L) small intestines. 
(A-H) Ki67 stainings show that prior to E16.5 proliferation throughout the epithelial lining (white arrowheads) is 
maintained in Tcf4-/-intestines. Periodic acid-Schiff (PAS) stainings (I and J) and anti-synaptophysin stainings 
(K and L) in E18.5 small intestines reveal a massive loss of goblet cells and enteroendocrine cells respectively in 
Tcf4 mutant intestines.  
 
In order to shed light on the genetic program regulated by Tcf4 during intestinal 
development, we performed microarray profiling on small intestines derived from normal or 
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Tcf4-/- littermates. We reasoned that the ideal developmental stage in which to carry out such 
analysis would be E15.5. At this stage proliferation within the epithelium is maintained in 
Tcf4 knockouts; therefore changes in gene expression observed in Tcf4 mutants are more 
likely to reflect the loss of Tcf4 rather than the absence of cellular compartments, as would be 
the case when comparing intestines at later stages (E16.5 and beyond). E15.5 whole small 
intestines from two wild-type and Tcf4-/- intestines derived from two independent litters were 
harvested and profiled using Agilent Whole Genome Mouse arrays. As shown in 
supplementary Table I we selected genes, which were significantly (p≤ 0.05) up or 
downregulated at least 1.5 fold in Tcf4-/- intestines. Based on this criterion, we found over 
100 genes downregulated and over 200 genes upregulated in Tcf4-/- guts. These genes were 
further categorized into functional groups based on their predicted or known expression 
patterns in the intestine (see complete list of genes at 
http://www.niob.knaw.nl/researchpages/clevers/files/Completelist.xls). 
 
Enterocytic markers are upregulated in Tcf4-/- small intestines 
As previously shown in our laboratory (69), inhibition of Wnt signaling in colon 
cancer cell lines results in upregulation of intestinal differentiation markers. To examine 
whether this observation holds true in the fetal small intestine we examined the list of 
upregulated genes in Tcf4 mutant guts. As shown in Table I removal of Tcf4 resulted in an  
 
 
Figure 2. Upregulation of enterocyte 
markers in Tcf4-/- small intestines. 
In situ hybridization analysis of Fabp1 
(A-E), Creb3l3 (F-J), Nr1h4 (K-O) in 
wild-type and Tcf4-/- fetal intestines. 
Anterior and posterior regions of the fetal 
intestinal tract are depicted in panels (A, 
B, F, G, K, L) and panels (C, D, H, I, M, 
N) respectively. Expression levels of 
enterocytic markers are strongly 
upregulated in the distal Tcf4-/-intestine 
and also the intervillus regions (black 
arrowheads) of the proximal Tcf4-/-
intestine. Panels (E, J, O) confirm that 
Fabp1, Creb3l3, Nr1h4 are enterocytic 
markers in the mature intestine. 
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increase in genes specifically expressed in differentiated enterocytes (ie. Apo4, Fabp1, Fabp2, 
Creb3l3, etc.). To validate these findings we performed in situ hybridizations on sections of 
E15.5 wild-type and Tcf4 mutant small intestines using probes specifically recognizing three 
enterocyte markers shown in Table I ie. Fabp1, Creb3l3 and Nr1h4. As shown in Figure 2, in  
wild-type embryos all three markers were limited to the emerging villi in the anterior regions 
and were barely detectable in the distal regions of the intestine. However, in Tcf4 mutant 
embryos Fabp1, Creb3l3 and Nr1h4 were strongly expressed in both propective villus and 
intervillus regions (Figure 2, see arrowheads), and where ectopically expressed in the distal 
regions of the intestine (Figure 2). Finally, in Figure 2E, J, O we showed that in the mature 
adult intestine Fabp1, Creb3l3 and Nr1h4 were confined to villus enterocytes and 
undetectable in crypts, indicating that these genes are indeed markers of fully differentiated 
enterocytes. 
 
Loss of crypt progenitor markers in Tcf4-/- small intestines 
Gene expression profiling in normal and colon cancer cells has shown that Wnt signaling 
promotes the expression of genes typically found in crypt progenitor cells (69;73). We now 
show based on our analysis of downregulated genes in Tcf4-/- intestines that, long before the 
formation of proper crypts, Tcf4 drives the expression of several known crypt progenitor 
markers (ie. Sox9 (279) , cMyc (69), Gpx2(280) ,c-Myb (281) and Axin2 (149), etc.). In Figure 
3, we confirmed these findings by showing that both c-Myc and c-Myb expression was  
 
 
 
 
 
 
Figure 3. Downregulation of crypt progenitor 
markers in Tcf4-/- small intestines. 
In situ hybridization analysis of c-Myc (A-B), c-
Myb (C-D), Hop (E-F), TcfAP4 (G-H) and Vav3 
(I-J) in fetal and adult small intestines.  
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severely abrogated in the Tcf4-/- intetinal epithelium. Besides these established Tcf 
responsive genes we uncovered novel crypt progenitor markers such as the homeodomain 
only protein, Hop; the helix-loop-helix transcription factor, Tcfap4; and the Rho family 
guanine nucleotide exchange factor, Vav3. 
 
Loss of secretory lineage markers in Tcf4-/- small intestines 
As illustrated in Figure 1, Tcf4-/- small intestines display a loss of enteroendocrine 
cells and goblet cells. Consistent with these findings, microarray profiling showed several 
secretory lineage markers downregulated genes in Tcf4-/- guts. As illustrated in Figure 4 
wild-type intestines expressed, in discrete cells, abundant levels of goblet cell markers (ie. 
Tff3 (282-284), Gob4 (285), and Gob5 (286), enteroendocrine cell markers (ie. 
Cholecystokinin and Chromogranin B) and the dual Paneth and goblet cell marker, Spink4 
(251). However in Tcf4 mutant intestines the expression of these markers was severely 
impaired (Figure 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Downregulation of crypt progenitor markers in Tcf4-/- small intestines. 
In situ hybridization analysis of c-Myc (A-B), c-Myb (C-D), Hop (E-F), TcfAP4 (G-H) and Vav3 (I-J) in fetal wt 
(A, C, E, G, I, K) and Tcf4-/- (B, D, F, H, J, L).  
 
Given that removal of Tcf4 resulted in a specific blockage in the differentiation of 
secretory cells, we next tested whether Tcf4 controls the expression of known cell fate 
determinants. As was discussed earlier, all secretory cell types are derived from early 
progenitor cells expressing the transcription factor Math1.  Moreover Math1 deficiency 
results in a complete loss of secretory lineages (95). In Figure 5i and ii we found both by 
immunohistochemistry and RT-PCR that Math1 expression levels were reduced in Tcf4-/- 
intestines. In Tcf4 mutants, the only remaining Math1 positive cells were restricted to the 
most anterior and distal regions of the small intestine in accordance with our histological 
analysis of Tcf4 mutants at E18.5 in Figure 1 (data not shown). Another key regulator of 
secretory lineage commitment is Hes1. As a target gene of Notch signaling, Hes1 represses 
Math1 expression and thereby promotes commitment away from secretory lineages, towards 
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the enterocytic lineages (96). As shown in Figure 5i and ii, contrary to Math1, Hes1 levels 
were unaffected in Tcf4 mutant intestines. Finally to rule out the possibility that alterations in 
other Hes family members were responsible for the reduction in Math1 we compared the 
levels of three Hes genes known to be expressed in the intestine Hes5, Hes6, Hes7 (278). 
Again however we found no differences in the expression levels of Hes5, Hes6, Hes7 between 
wild-type and Tcf4 mutant intestines (Figure 5ii). 
 
 
Figure 5. Downregulation 
of cell fate determinants in 
Tcf4-/-  small intestines. 
(i) Immunohistochemistry 
and in situ hybridization 
analysis of Math1 and Hes1 
respectively. (ii) RT-PCR 
analysis on wild-type, 
Tcf4+/- and Tcf4-/- intestines 
for Math1, Ngn3, Pax4, 
NeuroD, Hes1, Hes5, Hes6, 
Hes7 and β-actin. (iii) In situ 
hybridization analysis on 
wild-type and Tcf4-/- 
intestines for the candidate 
goblet cell determinants Klf4 
and Spdef. Expression of all 
secretory lineage cell fate 
determinants were 
downregulated in Tcf4-/- 
intestines, whereas Hes 
family members were 
unchanged. 
 
 
 
 
 
 
 
 
 
 
 
 
Dowstream of Math1, commitment towards either enteroendocrine cells, goblet cells 
or Paneth cells depends on the activation status of various transcription factors. For example 
Ngn3 promotes enteroendocrine cell commitment, while other factors, such as NeuroD, 
Nkx2.2 and Pax4, regulate the differentiation of specifc enteroendocrine sublineages (99). 
Besides enteroendocrine cells however little is known about the factors regulating the 
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formation of goblet cells and Paneth cells. Loss of function studies in mice have pointed to 
Kruppel-like factor 4, Klf4, as a possible candidate specifically driving goblet cell 
differentiation (100).  Based on co-expression studies with the goblet cell marker Tff3, we 
identified the Ets family transcription factor, Spdef, as another putative goblet cell regulator 
and a Tcf4 responsive gene (Supplementary Figure 1).  In agreement with our initial finding 
that Tcf4 regulates Math1 expression, we observed a strong reduction in the levels of Ngn3, 
Pax4, NeuroD, Klf4, and Spdef in Tcf4-/- intestines (Figure 5ii and iii). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 1. Spdef is a marker of goblet cells. 
(A-B) In situ hybridization analysis of Spdef in E18.5 small intestine and APCmin adenomas. (C-D) Double 
fluorescence in situ hybridization (FISH) analysis of the Spdef (green labelings, Alexa Fluoro 488) and Tff3 (red 
labelings, Alexa Fluoro 546) in the adult intestine. (E-H) DIC images of an intestinal crypt (panel E) and villus 
(panel H) superimposed on Spdef and Tff3 stainings.  
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Discussion 
 
In this study we provide a detailed account of the global gene expression profiles in 
Tcf4-/- fetal intestines. Our microarray analysis was performed on whole small intestines at a 
developmental stage prior to the massive loss of progenitor cells observed in Tcf4 mutants. As 
a result we identified three categories of Tcf4 responsive genes: upregulated enterocyte 
differentiation markers as well as downregulated crypt progenitor and secretory lineage 
markers. 
 
 
Figure 6. Model for the role of 
Tcf4 in intestinal epithelial cells. 
Our data implies a model whereby 
Tcf4 promotes: 1) renewal of 
progenitor cells in part through 
activation of c-Myc; 2) inhibition of 
enterocyte differentiation through 
direct or indirect transcriptional 
repression of markers such as 
Fabp1, Creb3l3, Nr1h4, etc.; 3) 
commitment towards secretory 
lineages through transcriptional 
activation of Math1. 
 
 
 
 
 
 
 
 
As shown in Figure 2 and Table I, loss of Tcf4 resulted in a robust increase in the 
expression of genes associated with differentiated enterocytes. This increase was particularly 
evident in the distal portion of the small intestine, implying that the genetic program 
regulating enterocytic differentiation was prematurely turned on in Tcf4 mutants.  How 
exactly Tcf4 regulates enterocyte lineage commitment is unclear. As shown in Figure 5, we 
found no evidence to suggest that effects on enterocyte differentiation were mediated by 
changes in the expression of Hes genes. Alternatively, the precipitated increase in enterocyte 
makers may reflect changes in expression levels of cell cycle regulators. Work from our 
laboratory has previously shown that in colon cancer cells down regulation of c-Myc, as a 
consequence of inactivation of Tcfs, deprepresses the cell cycle inhibitor p21(Cip/WAF1) 
(69). Moreover, the increase in p21 levels was found to be necessary and sufficient to induce 
cell cycle arrest and differentiation of colon cancer cells (69).  Similarly in the fetal intestine, 
we find that c-Myc expression is reduced in Tcf4 mutants, and therefore we may hypothesis 
that in this context, cell cycle inhibitors are consequently upregulated and possibly drive early 
differentiation of progenitors into enterocytes. Finally, our results may also suggest a model 
83 
Intestinal epithelial differentiation in Tcf4 mutants 
whereby Tcf4 actively represses the expression of enterocytic markers, through the 
recruitment of general transcriptional repressors as was put forward previously (50;51). 
 
As anticipated based on previous microarray studies, we found that a significant 
fraction of downregulated genes in Tcf4-/- intestines represented markers of crypt progenitor 
cells (ie. c-Myc, Sox-9, Gpx2). By far the best characterized of these Tcf4 target genes is c-
Myc. Unpublished work in our laboratory has shown that conditional loss of c-Myc in the 
adult intestine results in reduced crypt epithelial cell proliferation and growth (Muncan V and 
Clevers H, manuscript submitted). Recently similar studies performed have uncovered an 
additional role for c-Myc in the formation of crypt structures (287). Therefore altogether these 
data indicate that Tcf4 maintains the self renewing capacity of epithelial progenitor cells, at 
least, in part by regulating c-Myc expression. 
 
In addition to known crypt progenitor markers our study has identified three novel 
Tcf4 target genes: Hop, Tcfap4 and Vav3. Hop was discovered as a gene highly expressed in 
the developing heart and shown to play an essential role in regulating serum response factor 
mediated transcription (288;289). Vav3 along with the other Vav family members are guanine 
nucleotide exchange factors involved in regulating cytoskeletal rearrangements as well as 
signal transduction events downstream of tyrosine kinases (290). Most studies examining Vav 
function have focused on lymphophocyte development and activation (291), although a recent 
report has shown that Vav3 is a key regulator of bone density and osteoclast function 
(292).The biological role of Tcfap4 remains unknown. 
 
The most strongly downregulated genes in Tcf4-/- intestines were differentiation 
markers of goblet cells, enteroendocrine cells and Paneth cells. This observation prompted us 
to examine whether early commitment of progenitor cells towards a secretory cell fate was 
impaired in Tcf4 mutants. Indeed we found Math1 expression strongly reduced in the absence 
of Tcf4 and consequently specific cell fate determinants downstream of Math1, such as Ngn3, 
Pax4, NeuroD etc. were also impaired. To follow up these observations it will be interesting 
to test whether Math1 is a direct Tcf4 target gene. 
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Table I. Selected list of Tcf4 responsive genes 
Genes downregulated in Tcf4-/-E15.5 small intestine     
Gene Name Accession number Fold change  p value 
Paneth cell markers       
cryptdin 6 (Defcr6) NM007852 -27.29 7.78E-28 
cryptdin 2 (Defcr2) AH005399 -20.98 2.99E-25 
defensin related cryptdin peptide (Defcr) NM010031 -19.10 1.96E-27 
cryptdin 3 (Defcr3) NM007850 -16.39 2.72E-28 
serine protease inhibitor, Kazal type 4 (Spink4) NM011463 -11.74 1.47E-16 
cryptdin 4 (Defcr4) NM010039 -8.93 2.06E-19 
P lysozyme structural (Lzp-s) NM013590 -1.71 1.92E-02 
Enteroendocrine cell markers       
chromogranin B (Chgb) NM007694 -14.17 5.11E-30 
secretin (Sct) NM011328 -12.41 6.83E-30 
glucagon (Gcg) NM008100 -12.17 1.21E-08 
ghrelin (Ghrl) NM021488 -7.00 5.47E-11 
cholecystokinin (Cck) NM031161 -4.60 1.34E-07 
Goblet cell markers       
chloride channel calcium activated 3 (Clca3/Gob5) NM017474 -27.04 4.57E-31 
anterior gradient 2 (Agr2/Gob4) NM011783 -18.16 1.37E-30 
serine protease inhibitor, Kazal type 4 (Spink4) NM011463 -11.74 1.47E-16 
trefoil factor 3, intestinal (Tff3) NM011575 -10.99 3.48E-29 
SAM pointed domain containing ets (Spdef) NM013891 -3.46 4.15E-02 
Kruppel-like factor 4 (Klf4) NM010637 -1.45 6.35E-03 
Crypt progenitor markers       
SRY-box containing gene 9 (Sox9) NM011448 -7.56 5.55E-09 
glutathione peroxidase 2 (Gpx2) NM030677 -6.95 4.93E-20 
vav 3 oncogene (Vav3) NM146139 -3.40 7.62E-03 
homeobox only protein (Hop) NM175606 -2.52 5.63E-06 
myelocytomatosis oncogene (Myc) NM010849 -2.19 4.51E-04 
myeloblastosis oncogene (Myb) NM033597 -2.16 1.29E-03 
inhibitor of DNA binding 1 (Idb1) NM010495 -1.85 2.67E-06 
Genes upregulated in Tcf4-/- E15.5 small intestine     
Gene Name Accession number Fold change  p value 
Enterocyte markers       
nuclear receptor subfamily 1, group H, member 4 NM009108 1.93 4.36E-07 
fatty acid binding protein 2, intestinal (Fabp2) NM007980 2.07 6.22E-09 
fatty acid binding protein 1, liver (Fabp1) NM017399 2.29 1.06E-10 
cAMP responsive element binding protein 3-like 3  NM145365 2.49 1.21E-11 
solute carrier family 26, member 1 (Slc26a1) NM174870 2.60 1.76E-02 
alpha fetoprotein (Afp) NM007423 3.79 1.19E-18 
apolipoprotein A-IV (Apoa4) NM007468 4.64 5.15E-21 
alcohol dehydrogenase 1 (class I) (Adh1) NM007409 4.66 1.23E-21 
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 Summarizing Discussion  
 
 More than 20 years ago the founding member of the Wnt gene family, Wnt-1/Int1, 
was discovered as a proto-oncogene activated in mammary gland tumors by the mouse 
mammary tumor virus (MMTV) (293;294). Intense investigation by numerous laboratories 
has since clearly shown that Wnt genes and their downstream effectors play an essential role, 
not only during carcinogenesis, as was originally assumed, but also in a wide array of 
developmental processes.  The major thrust of this thesis was to examine the function of Wnt 
signaling during early gut development, as well as intestinal organogenesis and homeostasis.   
 
 As a functional model to study Wnt signaling in this context we utilized mouse lines 
deficient for the T cell factors: Tcf4 and Tcf1. Tcf family members are obligatory mediators 
of Wnt induced transcriptional activation and consequently are considered essential 
components of the canonical Wnt cascade.  In response to Wnt stimulation, Tcfs activate 
transcription by forming a complex with β-catenin, which in turn serves to further recruit 
general transcriptional modulators such as Brg1 and CBP (41;43;295). As with many other 
transcription factors, in the absence of coactivators, Tcfs may recruit general repressors and 
thereby actively shut off transcription of target genes (50;51). In this thesis we provide 
genetic evidence that the activator and possibly repressor functions of Tcfs are required for 
proper patterning and cytodifferentiation of the gastrointestinal tract.  
 
 In Chapter 2, we characterized the phenotype of compound Tcf4-/-/Tcf1-/- embryos. 
These mutants developed major developmental defects consisting of severe posterior 
truncations and early gastrointestinal malformations. The first abnormality observed was the 
apparent absence of hindgut, as documented by the complete loss of endodermal markers in 
the posterior region of Tcf4-/-/Tcf1-/- embryos. Although this was not addressed in Chapter 2, 
at least three possible explanations may account for the defects in hindgut formation. Firstly, 
Wnt/Tcf signals may be stimulating proliferation of posterior endodermal cells, as is known 
to occur at much later fetal stages in hindgut derivatives such as intestinal epithelial cells (66). 
Alternatively Tcf1 and Tcf4 may be promoting survival signals within endodermal cells. We 
believe that this scenario can be ruled out based on our observations that Tcf4/Tcf1 mutants 
do not show increased numbers of apoptotic cells, as evidenced by whole-mount TUNEL 
assays (unpublished data). Finally, besides mitotic effects, Tcf4 and Tcf1 may be regulating 
cell fate decision in early endodermal cells. Indeed in Chapter 2, we speculated that the 
ectopic neural tissue observed in the caudal regions of Tcf4-/-/Tcf1-/- embryos may derive 
from misspecified epiblast cells, which take on a neural fate instead of an endodermal fate.  
Similar events are thought to occur in Lef-/-/Tcf1-/- embryos, although in this case, presomitic 
mesoderm is transformed into neural tubes. It should be noted, however, that in Tcf4-/-/Tcf1-/- 
embryos the ectopic neural tissue appear as bifurcations of the neural tube and not neural 
tubes in place of hindgut. Consequently, the bifurcations of the neural tube may simply be a 
result of hyperproliferating neural cells, rather than cell fate changes in early epiblast cells. To 
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resolve this issue it will be necessary to determine at which time-point the ectopic neural 
tissue is first detected in Tcf4-/-/Tcf1-/- embryos.  
 
 Because Tcf4-/-/Tcf1-/- embryos survived until E15.5 we were able to assess the role 
of Tcf4 and Tcf1 during the patterning phase of the gut tube.  As a consequence of the early 
hindgut defects, Tcf4/Tcf1 mutants displayed severely truncated intestines. Surprisingly in 
these mutants, we found clear evidence of gastro-intestinal transformations. In particular, the 
region morphologically appearing as duodenum had taken on a gastric fate.  We hypothesized 
that this anterior transformation reflected a function for Tcfs in impeding the growth of the 
stomach.  Interestingly, in support of this idea we find that Tcf4-/- stomachs display a 
substantial increase in the number of proliferative epithelial cells, suggesting that Tcf4 
represses proliferation in stomach epithelial cells (unpublished observations). Whether this 
function depends on Tcf4-mediated transcriptional activation or repression remains to be 
resolved. Moreover if inhibition of Wnt signaling relieves growth constraints imposed upon 
the stomach during gut patterning, one may consider the possibility that under normal 
circumstances Wnt activity is effectively blocked in the prospective stomach regions of the 
gut tube. One possible mechanism to suppress Wnt signaling in the stomach has recently been 
proposed. Shivdasani and colleagues have shown that loss of the stomach specific 
transcription factor Barx1 prevents stomach epithelial differentiation (296). These authors 
went on to show that Barx1 specifies gastric fate through its ability to promote the transient 
expression of secreted Wnt antagonists sFRP1 and sFRP2 in the stomach mesenchyme. 
 
 In Chapter 3, we moved beyond gut development to study the localization of Wnt 
signaling components in the mature adult intestine. Despite the wealth of genetic evidence 
supporting a role for Wnt signaling in the adult intestine, very little was known regarding the 
expression pattern of individual Wnts and their downstream signaling components in the 
intestine. Previously several authors hypothesized that the Wnt ligands driving proliferation 
of crypt epithelial cells would be expressed in surrounding mesenchymal cells (87;88). 
Although we found several Wnts expressed in the villus mesenchyme none were detected in 
crypt regions, implying that proliferation of epithelial cells may solely be driven by autocrine 
Wnt signals. Otherwise, we can only conclude that crypt mesenchyhmal Wnts are expressed 
below the detection levels of our in situ hybridization protocol. The expression of Wnts and 
Fzs in the differentiated compartments of the crypt/villus axis, including Wnt4, Wnt5a, 
Wnt2b, Fz4, Fz6 implicated a role for non-canonical Wnt signaling in the intestine. As an 
attempt to uncover what this function might be we have since examined intestines derived 
from single Wnt5a and Wnt4 mutant mice. Histological analysis, however, revealed no 
obvious abnormalities (data not shown). Unlike the classical Wnt/β-catenin pathway, which 
has one major endpoint, non-canonical Wnts induce pleiotropic cellular responses.  These are 
often categorized into two branches, including the so-called planar cell polarity (PCP) 
pathway and the Wnt-Ca++ pathway. The former stimulates cytoskeletal rearrangements 
through activation of the small GTPases Rho and Rac, whereas the Wnt- Ca++ pathway relies 
on the following effectors phospholipase C (PLC), calcium-calmodulin-dependent kinase 2 
(CamK2) and protein kinase C (PKC) (297). Complicating matters further is the fact that 
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these non-canonical signaling components are also regulated by numerous other extracellular 
stimuli besides Wnts. Consequently a clear picture of the role for this pathway has yet to 
emerge. 
 
  Besides evidence for non-canonical signaling, our screen revealed a putative role for 
secreted Wnt antagonists, including Wif, Dkk2, Dkk3, sFRP1 and sFRP5. The most intriguing 
of these factors appears to be sFRP5, based on its restricted expression immediately above the 
Paneth cells. The precise localization of intestinal stem cells is subject to much debate. The 
classical view based on radiolabeling experiments suggests that in the small intestine stem 
cells reside on average around the fourth cell position from the crypt bottom (298). However 
other reports have proposed that proliferative columnar cells (in-between Paneth cells) at the 
crypt bases represent the bone fide stem cell compartment (299;300). Assuming sFRP5 is 
uniquely expressed in stem cells, we may ask what role a Wnt antagonist may play in 
regulating intestinal stem cells. One of the hallmarks of stem cells is their reduced mitotic rate 
when compared to other crypt progenitor cells (301). Therfore sFRP5 may be required to 
maintain stem cells in a relative quiescent state by locally blocking the stimulatory effect of 
Wnts on proliferation. Another important issue, assuming again this model to be correct, is 
how sFRP5 expression is activated specifically in stem cells.  Based on the absence of sFRP5 
in adenomas and most crypt progenitor cells it is unlikely that sFRP5 is regulated by Wnt 
signaling.  In the future it will be of interest to investigate whether other signaling pathways 
known to affect stem cell proliferation (eg. Notch and BMP signaling) regulate sFRP5 
expression. Recent work has highlighted a putative role for sFRP5 and other sFRPs in human 
colon cacerogenesis. The vast majority of human colon cancer cells appear to silence sFRP5 
expression through methylation. Consistent with the above-mentioned model, these latest 
findings suggest that downregulation of sFRP5 may provide cells with a growth advantage.   
  
 In Chapter 4 and 5, we identified Wnt/Tcf4 responsive genes during fetal intestinal 
development. In our initial microarray experiments, we noticed that the products of Paneth 
cells including cryptdins were amongst the most strongly downregulated genes in Tcf4-/- 
intestines. Paneth cells are differentiated intestinal epithelial cells which unlike other 
differentiated lineages reside at the very bottom of the crypts of Lieberkühn, express high 
levels of nuclear β-catenin and secrete at least two Wnt ligands (Wnt3 and Wnt9b). To 
demonstrate that Paneth cells depend on Wnt signaling to drive part of their genetic program 
we utilized Fz5 conditional mutant mice. As a result of defective expression of the Tcf target 
gene, EphB3, Fz5 deficient Paneth cells did not home the bottom of the crypts but rather 
scattered throughout the epithelial lining. In these mis-positioned Paneth cells cryptdin 
expression was abrogated. This result indicated that Wnt signaling controls proliferation of 
progenitors but also drives maturation of epithelial cells by regulating a post-mitotic genetic 
program. 
 
 In Chapter 5, a more exhaustive analysis of Tcf4 responsive genes allowed us to 
further propose that Wnt/Tcf4 signals are involved in commitment of progenitor cells towards 
secretory lineages and that Tcf4 negatively regulates enterocyte differentiation. Indeed in 
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Tcf4-/- intestines we found a reduction in secretory cell fate determinants such as Math1 as 
well as Ngn3, NeuroD, Pax4 etc. and upregulation of enterocyte markers. Importantly these 
Tcf4-mediated effects were independent of Hes1, the well established Math1 repressor and 
early enterocyte determinant. 
 
 A number of questions arise from these observations. Firstly, how does Tcf4 regulate 
Math1 expression? To answer this question we are now looking at the possibility that Tcf4 
directly activates transcription of the Math1 gene. Obviously we must also consider the 
possibility that Tcf4 regulates Math1 via an indirect route. Regardless of the mechanism it is 
clear that Math1 expression is not entirely blocked following loss of Tcf4. Math1 positive 
cells were frequently detected near the gastro-duodenal junction and the very distal portion of 
Tcf4-/- intestines, albeit at reduced levels when compared to wild-type intestines (data not 
shown). These positional effects suggest that other factors can compensate for or take over 
Tcf4 function, depending on the compartment of the intestinal tract one is examining. Further 
supporting this view is our observation that at E18.5 in the proximal portion of the colon, loss 
of Tcf4 does not result in any changes in goblet cells numbers, despite the absence of 
proliferative cells (data not shown). It is unclear from the current reading of the literature 
whether these positional effects also occur in other mouse models displaying defective Wnt 
signaling in the intestine (ie β-catenin-/- and DkkTg mice) (65;68).  
 
 On a related issue we may also question how Tcf4 negatively regulates the expression 
of enterocyte markers. . In Chapter 4, we demonstrated that Tcf4 promotes Paneth cell 
differentiation by directly activating cryptdin gene expression. In a similar manner we may 
propose that Tcf4 inhibits enterocyte maturation by directly repressing markers such as 
Fabp1, Creb3l3 and Nr1h4 etc. As with Math1, chromatin immunoprecipitation experiments 
will need to be performed to verify this hypothesis. As an alternative explanation, in Chapter 
5 we discussed an attractive model initially proposed by van de Wetering et al. (69), whereby 
Tcf4 indirectly regulates enterocyte differentiation by controlling c-Myc, and in turn, 
p21WAF/CIP1 levels. Loss and gain of function experiments suggest that in progenitor cells 
p21 is repressed by c-Myc, and as c-Myc levels drop, p21 is derepressed and can stimulate 
differentiation of progenitors. To test this hypothesis we are now examining whether 
expression of p21 precedes or coincides with the increase in expression of enterocyte markers 
seen in Tcf4-/- intestines. If so, this observation would provide indirect evidence supporting 
the above model. In this context it would also be interesting to verify whether the ectopic 
increase of enterocytic markers as a result of the inactivation of Tcf4 is blocked in a p21 
deficient background. Besides p21 we shall also examine other cell cycle inhibitors, such as 
p27KIP1 and p57KIP2, both of which have been linked to differentiation processes in 
intestinal epithelial cells (302;303).  
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ISH: in situ hybridisation;  
Wnt: Wingless and int-1;  
Fz: Frizzled;  
LRP: low-density lipoprotein (LDL)-receptor-related protein;  
sFRP: secreted frizzled-related protein;  
WIF: Wnt-interacting factor;  
Dkk: Dickkopf;  
TCF: T-cell factor;  
LEF: lymphoid enhancer factor 
APC: Adenomatous polyposis coli 
CRC: Colorectal cancer 
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Summary 
 
The Wnt pathway controls diverse biological processes during embryonic 
development. In the adult, Wnts maintain the balance between cell division and cell 
specialisation in tissues such as the hemapoetic system, skin, and the intestine. Genetic 
modifications which activate the Wnt pathway are also closely linked to unrestricted cell 
growth and malignancy. In this thesis we focused on the specific role of the Wnt pathway 
during normal intestinal development and homeostasis. To this end, we utilized so-called 
knockout mice which harbour mutations in the essential componenents of the pathway and 
studied the molecular consequences of these mutations by in situ hybridization, a technique 
which allows one to visualize the expression of gene products in tissues. 
 
In Chapter 2 we studied the consequences of deleting two Wnt effector proteins Tcf4 
and Tcf1 compound null embryos. Mouse lacking the gene products of both Tcf1 and Tcf4 
showed severe caudal truncations of the body, as well as duplications of the neural tube. 
Unlike other mutations affecting Wnt signaling, paraxial mesoderm formation was not 
impaired and early caudal markers, such as T, were unaffected. Analysis of endodermal 
markers uncovered early and specific defects in hindgut expansion and later an anterior 
transformation of the gastro-intestinal tract. Our results reveal a novel role for Wnt signalling 
in early gut morphogenesis and suggest that specific Wnt-driven patterning events are 
determined by the unique tissue distribution of Tcf/Lef family members. 
 
 In Chapter 3 we performed a large scale in situ hybridisation screen to examine the 
expression pattern of all Wnts, Fzs, LRPs, Wnt antagonists and TCFs in the murine small 
intestine, colon and adenomas. Our analysis revealed high expression of several signaling 
components (including Wnt-3, Fz-7,) in crypt epithelial cells.  We also detected gene products 
such as Wnt-2 and Fz-6 in differentiated epithelial and/or mesenchymal cells of the small 
intestine and colon. Finally, several factors (TCF-1, Dkk-3) displayed differential expression 
in normal versus neoplastic tissue. This study predicted a much more complex role for Wnt 
signaling in gut development and homeostasis than was previously anticipated. 
 
In Chapter 4 we found that inactivation of Tcf4 in the embryonic intestine and 
conditional deletion of the Wnt receptor Frizzled-5 in the adult intestine abrogated a specific 
Paneth cell genetic program. Paneth cells secrete microbicidal peptides, such as cryptdins, 
important in fighting bacterial infections. Moreover these Paneth cells reside at the very 
bottom of the intestinal crypts. In Tcf4 and Fz-5 mutant mice we observed a defect in the 
production of Paneth cell gene products and a scattering of Paneth cells throughout the crypt-
villus axis. Conversely, adenomas in APC mutant mice and colorectal cancers in man 
inappropriately expressed these Paneth cell genes, providing additional support that the 
expression of these genes is driven by active Wnt signals. Furthermore, these observations 
implied that Wnt signals in the crypt can separately drive a stem-cell/progenitor gene program 
and a Paneth cell maturation program.   
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 Finally in Chapter 5 we studied in more detail the defects associated with loss of Tcf4 
in the intestine. Deletion of Tcf4 results in neonatal death and a complete loss of proliferative 
stem cells in the intestine. By monitoring the gene products of specialized cell-types we found 
that absorptive cell markers (ie. Fabp1, Creb3l3, Nr1h4, etc.) were upregulated in Tcf4 
knockout embryos. Concomitantly, loss of Tcf4 resulted in specific downregulation of 
secretory lineage markers (ie. Tff3, Chromogranin B, and Spink4, etc.) and crypt progenitor 
markers (ie. c-Myc, c-Myb, TcfAP4, etc).  Further analysis suggested that Tcf4 promotes early 
commitment of secretory lineages through activation of the basic helix-loop-helix 
transcription factor, Math1. Moreover we found that Tcf4-mediated effects on cell fate were 
independent of any changes in the expression of Hes family members. Finally our results 
imply a model whereby Tcf4 coordinates renewal of progenitor cells, repression of enterocyte 
differentiation and commitment towards secretory lineages via Math1.
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Samenvatting  
(Marc Vooijs PhD) 
 
 De Wnt signalering keten dirigeert een verscheidenheid aan biologische processen 
gedurende embryonale ontwikkeling in zoogdieren. Ook in volwassenen, reguleren Wnt 
eiwitten de balans (homeostase) tussen celdeling (proliferatie) en celspecialisatie 
(differentiatie) in bijvoorbeeld de huid, de darmen en de vorming van bloedcellen. Verstoring 
van deze balans door bijvoorbeeld genetische veranderingen in het DNA leidt tot ongeremde 
groei van cellen en uiteindelijk tot kanker. In dit proefschrift hebben we ons gericht op rol die 
Wnt eiwitten hebben op darmontwikkeling en homeostase. Door gebruik te maken van 
genetische gemodificeerde muizenstammen die specifieke genproducten niet meer kunnen 
maken (knockout muis) kunnen we onderzoeken wat de functie van dit eiwit is op de normale 
darmontwikkeling. 
 
 In hoofdstuk 2 beschrijven we de consequenties van de afwezigheid van twee 
belangrijke componenten van de Wnt signaaltransductieroute; Tcf-1 en Tcf-4 op 
(darm)ontwikkeling in muizen. De afwezigheid van de Tcf-1 en Tcf-4 eiwitten in muizen leidt 
tot een ernstige verstoring van de embryonale ontwikkeling, in het bijzonder tot een complete 
afwezigheid van de achterpoten en staart en een verdubbeling van neurale buis structuren. In 
de vroege darmontwikkeling leidt de afwezigheid van Tcf-1 en Tcf-4 tot een defect in de 
uitgroei van het meest naar achter gelegen structuren. Een gedetailleerde analyse van markers 
voor darm cel specificatie toonde aan dat er een defect in cel identiteit was opgetreden 
zodanig dat de normaliter meer naar achter gelegen structuren de identiteit aannamen van 
meer naar voren gelegen darm (anteriore transformatie). 
Deze resultaten brengen een nieuwe rol voor Wnt eiwitten aan het licht in de aanleg en 
vorming van de eerste darmstructuren die gekaracteriseerd worden door de aanwezigheid van 
een uniek patroon van Tcf-1 en Tcf-4 gen expressie. 
 
 In hoofdstuk 3 beschrijven we een gen-expressie analyse van de meeste componenten 
van de Wnt signalering cascade waaronder alle tot nu toe bekende Wnt eiwitten, Frizzeld’s 
(Fz) en LRP’s de receptor en co-receptor voor Wnt eiwitten respectievelijk, natuurlijke 
remmers van Wnt eiwitten (Dickkopff) en Tcf factoren in de darmen van normale muizen en 
die van muizen met darm kanker. Uit deze analyse bleek dat sommige Wnt’s en hun Fz 
receptor alleen in de ongespecialiseerde darm epitheel cellen tot expressie kwamen (b.v. Wnt-
3 en Fz7) terwijl anderen in het meer gedifferentieerde darm epitheel (Wnt2b, Fz6). Tevens 
bleken sommige Wnt’s uitsluitend in het, naast het epitheel liggende, steun weefsel tot 
expressie te komen suggererend dat er een intieme communicatie is tussen deze twee cel 
typen dat normale cellulaire homeostase reguleerd. Bovendien vonden we verschillen in 
expressie van verscheidene componenten tussen de normale darm en darm tumoren (Tcf-1, 
Dickopff). Deze informatie leidt tot nieuwe inzichten in de complexiteit van de mogelijke 
interacties tussen componenten van de Wnt signaleringsroute met het omliggende 
darmweefsel en verstoring daarvan tijdens darm kanker ontwikkeling. 
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  In hoofdstuk 4 beschrijven we de consequenties van de afwezigheid van Frizzled-5 
(Fz-5) op darmontwikkeling en functie in volwassen muizen. In de normale volwassen darm 
vindt een continue proces plaats van cel vernieuwing dat er voor zorg draagt dat uitgerijpte 
gespecialiseerde darm cellen na ongeveer een week vervangen worden door nieuwe. Dit 
proces wordt gereguleerd door stam cellen waarvan na deling de nakomelingen nieuwe cel 
identiteiten aannemen. Het aannemen van deze nieuwe identiteit en functie gaat gepaard met 
een opwaartse of neerwaartse verplaatsing van deze cellen in de darm structuren. Deling van 
darm stam cellen staat onder controle van de Wnt signaleringsketen. Muizen die het Tcf-4 
eiwit missen produceren geen darm stam cellen. Uitschakeling van Fz-5 in de darmen van 
muizen had geen effect op de functie van de stam cellen maar op de cel specialisatie van de 
cellen van Paneth. Deze cellen dragen ondermeer zorg voor bescherming tegen bacterieen in 
de darm. Normaliter bewegen de cellen van Paneth zich in een neerwaartse beweging na 
deling van de darm stam cel, echter in de afwezigheid van Fz5 bleek er een defect in de 
sortering van Paneth cellen. We vonden Paneth cellen terug in alle structuren van de darm 
waar ze normaliter niet thuis horen. Bovendien vonden we dat darm kanker cellen gen-
expressie patronen vertoonden van de gespecialiseerde Paneth cellen. Hiermee toonden we 
voor het eerst aan dat de Wnt signaleringsketen niet alleen een belangrijke rol heeft in de 
regulatie van stam cel deling maar ook een gerichte functie heeft in de uitrijping en sortering 
van de cellen van Paneth. 
 
 In hoofdstuk 5 hebben we ons gericht op de darm defecten van Tcf-4 knockout 
muizen. Afwezigheid van Tcf-4 in muizen is niet levensvatbaar maar leidt wel tot een 
normale ontwikkeling van darm structuren. Deze darmen missen echter stam cellen die na de 
geboorte noodzakelijk zijn voor de continue cel vernieuwing die dan plaatsvindt. 
Afwezigheid van Tcf-4 resulteert in een defect waardoor veel cellen de moleculaire identiteit 
van asorptieve cellen aannamen gepaard met een verlies is van stam cel identiteit. Uit onze 
analyse bleek gedurende normale darm ontwikkeling aansturing van het BHLH eiwit Math1 
door Tcf-4 essentieel bleek te zijn voor normale uitrijping darmepitheel. Omdat de activiteit 
van het Math1 ook onder invloed staat van de Notch signaleringroute onderzochten we of 
defecten van Tcf-4 op Math1 afhankelijk waren van Notch signalering, dit bleek echter niet 
zo te zijn. Samenvattend blijkt uit onze analyse dat Tcf-4 de balans tussen stam cel deling en 
differentiatie reguleert via Math1. 
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